WO2011015524A2 - Fungicide heterocycles derivatives - Google Patents

Fungicide heterocycles derivatives Download PDF

Info

Publication number
WO2011015524A2
WO2011015524A2 PCT/EP2010/061082 EP2010061082W WO2011015524A2 WO 2011015524 A2 WO2011015524 A2 WO 2011015524A2 EP 2010061082 W EP2010061082 W EP 2010061082W WO 2011015524 A2 WO2011015524 A2 WO 2011015524A2
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
halogen atoms
alkyl
group
amino
Prior art date
Application number
PCT/EP2010/061082
Other languages
French (fr)
Other versions
WO2011015524A3 (en
Inventor
Christian Beier
Jürgen BENTING
David Bernier
Philippe Desbordes
Christophe Dubost
Pierre-Yves Coqueron
Stéphanie Gary
Daniela Portz
Ulrike Wachendorff-Neumann
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of WO2011015524A2 publication Critical patent/WO2011015524A2/en
Publication of WO2011015524A3 publication Critical patent/WO2011015524A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the present invention relates to aryloxyalkyl-heterocycle derivatives, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
  • Q can be selected in a list of 7 various heterocycle groups substituted by various carbonylaminoderivatives and A can be selected in a list of 7various 5-menbered heterocycle groups.
  • the compounds disclosed in these two documents do not prove to provide a comparable utility than the compounds according to the invention.
  • the present invention provides aryloxyalkyl-heterocycle derivatives of formula (I)
  • Q 1 represents N or CY 3 ;
  • Y 1 , Y 2 , Y 3 and Y 4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, hydroxycarbonyl, C- ⁇ -C 8 -alkoxycarbonyl, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde 0-(C 1 -C 8 - alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted d-C 8 -alkoxyamino group, substituted or non-substituted N-C- ⁇ -C 8 -alkyl-(C- ⁇ -C 8
  • n 1 , 2, 3 or 4 ;
  • R 1 and R 2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C- ⁇ -C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non-substituted C- ⁇ -C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C 2 -C 8
  • T represents a hydrogen or a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T 1 to T 32 :
  • X 1 to X 4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N- Ci-C 8 -alkyl-(Ci-C 8 -alkoxy)-amino group, substituted or non-substituted (d-C 8 -alkylamino
  • W 1 independently represents a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted d-C 8 -alkyl, substituted or non-substituted tri(Ci-C 8 -alkyl)silyl-Ci-C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non- substituted tri(Ci-C 8 -alkyl)silyl-C 3 -C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 - halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -
  • Ci-C 8 -alkynyl substituted or non-substituted Ci-C 8 -alkylamino, substituted or non-substituted di- Ci-C 8 -alkylamino, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted Ci- C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C 2 -C 8 -alkenyloxy, substituted or non-substituted C 2 -C 8 -halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C 2 -C 8 -alkynyloxy, substituted or non-substituted C 3 -C 8 -halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 -alkyl,
  • Z ⁇ Z 2 , Z 3 , Z 4 Z 5 , Z 6 , Z 7 , Z 8 and Z 9 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted Ci-C 8 -alkoxyamino group, substituted or non-substituted N-C- ⁇ -C 8 -alkyl-(C- ⁇ -C 8 -alkoxy)-amino
  • K 1 and K 2 independently represent a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C- ⁇ -C 8 -alkyl, substituted or non-substituted tri(C 1 -C 8 -alkyl)silyl-C 1 -C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non- substituted tri(C 1 -C 8 -alkyl)silyl-C 3 -C 8 -cycloalkyl, substituted or non-substituted C 1 -C 8 - halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substitute
  • G 1 and G 2 are independently selected in the list consisting of oxygen, sulfur, NR 3 , N-OR 4 and N-NR 5 R 6 wherein R 3 to R 6 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C- ⁇ -C 8 -alkyl, substituted or non-substituted C 3 -C 8 - cycloalkyl, substituted or non-substituted C- ⁇ -C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 - alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non-substituted C- ⁇ -C 8 -alkoxy, substituted or non-substituted
  • Y 5 to Y 8 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non- substituted carbaldehyde O-(Ci-C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted C- ⁇ -C 8 -alkoxyamino group, substituted or non-substituted C 1 - C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 - halogen
  • any of the compounds according to the invention can exist as one or more stereoisomers depending on the number of stereogenic units (as defined by the IUPAC rules) in the compound.
  • the invention thus relates equally to all the stereoisomers and to the mixtures of all the possible stereoisomers, in all proportions.
  • the stereoisomers can be separated according to the methods which are known per se by the man ordinary skilled in the art.
  • halogen means fluorine, chlorine, bromine or iodine ;
  • heteroatom can be nitrogen, oxygen or sulphur ; • unless indicated otherwise, a group or a substituent that is substituted according to the invention can be substituted by one or more of the following groups or atoms: a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a pentafluoro- ⁇ 6 - sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde 0-(Ci-C 8 - alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, a (hydroxyimino)-C- ⁇ -C 6 -alkyl group, a C- ⁇ -C 8 -alkyl, a tri(Ci-C 8 - alky
  • halogen atoms a Ci-C 8 -alkylaminocarbonyloxy, a di-Ci-C 8 -alkylaminocarbonyloxy, a Ci-C 8 - alkyloxycarbonyloxy, a Ci-C 8 -alkylsulphenyl, a Ci-C 8 -halogenoalkylsulphenyl having 1 to 5 halogen atoms, a Ci-C 8 -alkylsulphinyl, a Ci-C 8 -halogenoalkylsulphinyl having 1 to 5 halogen atoms, a Ci-C 8 -alkylsulphonyl, a Ci-C 8 -halogenoalkylsulphonyl having 1 to 5 halogen atoms, a Ci- C 8 -alkylaminosulfamoyl, a di-Ci-C 8 -alkylaminosulfamoyl, a (d-
  • aryl means phenyl or naphthyl
  • heterocyclyl means saturated or unsaturated A-, 5-, 6- or 7-membered ring comprising up to 4 heteroatoms selected in the list consisting of N, O, S.
  • Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Y 1 , Y 2 , Y 3 and Y 4 independently represent a hydrogen atom, a halogen atom, a cyano group, a substituted or non- substituted carbaldehyde O-(Ci-C 8 -alkyl)oxime, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 - alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl.
  • More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Y 1 , Y 2 , Y 3 and Y 4 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 -alkoxy.
  • R 1 and R 2 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted C 1 -C 8 - alkyl.
  • More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein R 1 and R 2 independently represent a hydrogen atom.
  • Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T 27 to T 32 .
  • More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T 31 tO T 32 .
  • Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X 1 to X 4 independently represent a hydrogen atom, a halogen atom, a substituted or non-substituted carbaldehyde
  • O-(Ci-C 8 -alkyl)oxime substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted C 3 -C 8 - cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms.
  • More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X 1 to X 4 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C 8 -alkyl. Even more preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X 1 to X 4 independently represent a methyl group.
  • Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein W 1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non- substituted d-C 8 -alkoxy, substituted or non-substituted d-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, substituted or non- substituted
  • W 1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy and cyano.
  • W 1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy and cyano.
  • A is selected in the list consisting of A 1 to A 58 .
  • A is selected in the list consisting of A 2 , A 6 , A 8 , A 11 to A 18 .
  • Other preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Z 1 represents a hydrogen atom, a halogen atom, an amino group, a formylamino group, substituted or non- substituted Ci-C 8 -alkoxyamino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkoxy)-amino group, substituted or non-substituted Ci-C 8 -alkyl, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 - alkynyl, substituted or non-substituted d-C 8 -alkylamino,
  • Z 1 represents an amino group, a halogen atom, a formylamino group, a C 2 -C 8 -alkenyl, substituted or non- substituted C 2 -C 8 -alkynyl, substituted or non-substituted d-C 8 -alkylannino, substituted or non-substituted (Ci-C 8 -alkoxycarbonyl)annino, substituted or non-substituted (C 3 -C 8 -cycloalkoxycarbonyl)annino, substituted or non-substituted (C 2 -C 8 -alkenyloxycarbonyl)annino, substituted or non-substituted (C 3 -C 8 - alkynyloxycarbonyl)amino, substituted or non-substituted d-Cs-al
  • Z 2 to Z 9 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non- substituted d-C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non-substituted C 1 - C 8 -halogenoalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 - alkynyl, substituted or non-substituted d-C 8 -alkoxy, substituted or non-substituted d-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, substitute
  • Z 2 to Z 9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
  • K 1 and K 2 are independently selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
  • Preferred compounds of formula (Ia) to (Ic) according to the invention are those wherein Y 5 to Y 8 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C 8 -alkyl. More preferred compounds of formula (Ia) to (Ic) according to the invention are those wherein Y 5 to Y 8 independently represent a hydrogen atom or a fluorine atom.
  • preferred features of A with preferred features of one or more of T, Q 1 , Q 2 , Y 1 , Y 2 , R 1 , R 2 and n ; preferred features of T with preferred features of one or more of A, Q 1 , Q 2 , Y 1 , Y 2 , R 1 , R 2 and n ; preferred features Q 1 with preferred features of one or more of A, T, Q 2 , Y 1 , Y 2 , R 1 , R 2 and n ; - preferred features Q 2 with preferred features of one or more of A, T, Q 1 , Y 1 , Y 2 , R 1 , R 2 and n ; preferred features Y 1 with preferred features of one or more of A, T, Q 1 , Q 2 , Y 2 , R 1 , R 2 and n ; preferred features Y 2 with preferred features of one or more of A, T, Q 1 , Q 2 , Y 2 , R 1 , R 2 and n ; preferred features
  • the said preferred features can also be selected among the more preferred features of each of A, T, Q 1 , Q 2 , Y 1 , Y 2 , R 1 , R 2 and n ; so as to form most preferred subclasses of compounds according to the invention.
  • the present invention also relates to a process for the preparation of compounds of formula (I) and (Ia) to (Ic).
  • T, A, Q 1 , Q 2 , Y 1 , Y 2 , R 1 , R 2 and n are as herein-defined and LG represents a leaving group.
  • Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as triflate, mesylate, or tosylate.
  • the present invention also relates to a fungicide composition
  • a fungicide composition comprising an effective and non-phytotoxic amount of an active compound of formula (I).
  • fungicide composition comprising, as an active ingredient, an effective amount of a compound of formula (I) as herein defined and an agriculturally acceptable support, carrier or filler.
  • the term "support” denotes a natural or synthetic organic or inorganic compound with which the active compound of formula (I) is combined or associated to make it easier to apply, notably to the parts of the plant.
  • This support is thus generally inert and should be agriculturally acceptable.
  • the support can be a solid or a liquid.
  • suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports can also be used.
  • composition according to the invention can also comprise additional components.
  • the composition can further comprise a surfactant.
  • the surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants.
  • polyacrylic acid salts lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts
  • polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines substituted phenols (in particular alkylphenols or ary
  • surfactant content can be comprised from 5% to 40% by weight of the composition.
  • additional components can also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents.
  • the active compounds can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
  • composition according to the invention can contain from 0.05 to 99% by weight of active compound, preferably 10 to 70% by weight.
  • compositions according to the invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsifiable concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure),gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ULV) liquid, ultra low volume (ULV) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water soluble powder for seed treatment and wettable powder.
  • These compositions include not only compositions which are ready to be applied to the plant or seed to
  • the compounds according to the invention can also be mixed with one or more insecticide, fungicide, bactericide, attractant, acaricide or pheromone active substance or other compounds with biological activity.
  • the mixtures thus obtained have a broadened spectrum of activity.
  • the mixtures with other fungicide compounds are particularly advantageous.
  • the composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound can also be particularly advantageous.
  • fungicide mixing partners can be selected in the following lists:
  • Inhibitors of the ergosterol biosynthesis for example (1.1 ) aldimorph (1704-28-5), (1.2) azaconazole (60207-31-0), (1.3) bitertanol (55179-31-2), (1.4) bromuconazole (1 16255-48-2), (1.5) cyproconazole (113096-99-4), (1.6) diclobutrazole (75736-33-3), (1.7) difenoconazole (119446-68-3), (1.8) diniconazole (83657-24-3), (1.9) diniconazole-M (83657-18-5), (1.10) dodemorph (1593-77-7), (1.11 ) dodemorph acetate (31717-87-0), (1.12) epoxiconazole (106325-08-0), (1.13) etaconazole (60207-93-4), (1.14) fenarimol (60168-88-9), (1.15) fenbuconazole (114369-43-6
  • inhibitors of the respiratory chain at complex I or II for example (2.1 ) bixafen (581809-46-3), (2.2) boscalid (188425-85-6), (2.3) carboxin (5234-68-4), (2.4) diflumetorim (130339-07-0), (2.5) fenfuram
  • inhibitors of the respiratory chain at complex III for example (3.1 ) ametoctradin (865318-97-4), (3.2) amisulbrom (348635-87-0), (3.3) azoxystrobin (131860-33-8), (3.4) cyazofamid (120116-88-3), (3.5) dimoxystrobin (141600-52-4), (3.6) enestroburin (238410-11-2) (WO 2004/058723), (3.7) famoxadone (131807-57-3) (WO 2004/058723), (3.8) fenamidone (161326-34-7) (WO 2004/058723), (3.9) fluoxastrobin (361377-29-9) (WO 2004/058723), (3.10) kresoxim-methyl (143390-89-0) (WO 2004/058723), (3.11 ) metominostrobin (133408-50-1 ) (WO 2004/058723), (3.12) orysastrobin (18
  • Inhibitors of the mitosis and cell division for example (4.1 ) benomyl (17804-35-2), (4.2) carbendazim (10605-21-7), (4.3) chlorfenazole (3574-96-7), (4.4) diethofencarb (87130-20-9), (4.5) ethaboxam (162650-77-3), (4.6) fluopicolide (239110-15-7), (4.7) fuberidazole (3878-19-1 ), (4.8) pencycuron (66063- 05-6), (4.9) thiabendazole (148-79-8), (4.10) thiophanate-methyl (23564-05-8), (4.11 ) thiophanate (23564- 06-9), (4.12) zoxamide (156052-68-5), (4.13) 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6- trifluorophenyl)[1 ,2,4]triazolo[1 ,5-a]pyrimidine (2147)
  • Inhibitors of the amino acid and/or protein biosynthesis for example , (7.1 ) andoprim (23951-85-1 ), (7.2) blasticidin-S (2079-00-7), (7.3) cyprodinil (121552-61-2), (7.4) kasugamycin (6980-18-3), (7.5) kasugamycin hydrochloride hydrate (19408-46-9), (7.6) mepanipyrim (110235-47-7), (7.7) pyrimethanil (53112-28-0) and salts thereof.
  • Inhibitors of the ATP production for example (8.1 ) fentin acetate (900-95-8), (8.2) fentin chloride (639- 58-7), (8.3) fentin hydroxide (76-87-9) and (8.4) silthiofam (175217-20-6).
  • Inhibitors of the cell wall synthesis for example (9.1 ) benthiavalicarb (177406-68-7), (9.2) dimethomorph (110488-70-5), (9.3) flumorph (21 1867-47-9), (9.4) iprovalicarb (140923-17-7), (9.5) mandipropamid (374726-62-2), (9.6) polyoxins (1 1113-80-7), (9.7) polyoxorim (22976-86-9), (9.8) validamycin A (37248-47-8) and (9.9) valifenalate (283159-94-4; 283159-90-0).
  • Inhibitors of the lipid and membrane synthesis for example (10.1 ) biphenyl (92-52-4), (10.2) chloroneb (2675-77-6), (10.3) dicloran (99-30-9), (10.4) edifenphos (17109-49-8), (10.5) etridiazole (2593-
  • (11 ) Inhibitors of the melanine biosynthesis for example (11.1 ) carpropamid (104030-54-8), (11.2) diclocymet (139920-32-4), (11.3) fenoxanil (115852-48-7), (11.4) phthalide (27355-22-2), (11.5) pyroquilon (57369-32-1 ) and (11.6) tricyclazole (41814-78-2).
  • Inhibitors of the nucleic acid synthesis for example (12.1 ) benalaxyl (71626-11-4), (12.2) benalaxyl-M (kiralaxyl) (98243-83-5), (12.3) bupirimate (41483-43-6), (12.4) clozylacon (67932-85-8), (12.5) dimethirimol (5221-53-4), (12.6) ethirimol (23947-60-6), (12.7) furalaxyl (57646-30-7), (12.8) hymexazol (10004-44-1 ), (12.9) metalaxyl (57837-19-1 ), (12.10) metalaxyl-M (mefenoxam) (70630-17-0), (12.11 ) ofurace (58810-48-3), (12.12) oxadixyl (77732-09-3) and (12.13) oxolinic acid (14698-29-4).
  • Inhibitors of the signal transduction for example (13.1 ) chlozolinate (84332-86-5), (13.2) fenpiclonil (74738-17-3), (13.3) fludioxonil (131341-86-1 ), (13.4) iprodione (36734-19-7), (13.5) procymidone (32809- 16-8), (13.6) quinoxyfen (124495-18-7) and (13.7) vinclozolin (50471-44-8).
  • a method for controlling the phytopathogenic fungi of plants, crops or seeds characterized in that an agronomically effective and substantially non-phytotoxic quantity of a fungicide composition according to the invention is applied as seed treatment, foliar application, stem application, drench or drip application (chemigation) to the seed, the plant or to the fruit of the plant or to soil or to inert substrate (e.g. inorganic substrates like sand, rockwool, glasswool; expanded minerals like perlite, vermiculite, zeolite or expanded clay), Pumice, Pyroclastic materials or stuff, synthetic organic substrates (e.g. polyurethane) organic substrates (e.g.
  • a liquid substrate e.g. floating hydroponic systems, Nutrient Film Technique, Aeroponics
  • fungicide composition which is the subject of the invention can be applied by means of various methods of treatment such as:
  • the method according to the invention can either be a curing, preventing or eradicating method.
  • a composition used can be prepared beforehand by mixing the two or more active compounds according to the invention.
  • the dose of active compound usually applied in the method of treatment according to the invention is generally and advantageously
  • a lower dose can offer adequate protection.
  • the optimum dose usually depends on several factors, for example on the type of phytopathogenic fungus to be treated, on the type or level of development of the infested plant, on the density of vegetation or alternatively on the method of application.
  • the crop treated with the pesticide composition or combination according to the invention is, for example, grapevine, but this could be cereals, vegetables, lucerne, soybean, market garden crops, turf, wood, tree or horticultural plants.
  • the method of treatment according to the invention can also be useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots.
  • the method of treatment according to the invention can also be useful to treat the over-ground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruit of the concerned plant.
  • Solanaceae sp. for instance tomatoes
  • Solanaceae sp. for instance tomatoes
  • ⁇ liaceae sp. for instance lettuces
  • Umbelliferae sp. for instance lettuces
  • Umbelliferae sp. for instance lettuces
  • Umbelliferae sp. for instance lettuces
  • Cilionaceae sp. for instance peas
  • Rosaceae sp. for instance strawberries
  • major crops such as Graminae sp. (for instance maize, lawn or cereals such as wheat, rice, barley and triticale), Asteraceae sp. (for instance sunflower), Cruciferae sp.
  • the composition according to the invention can also be used against fungal diseases liable to grow on or inside timber.
  • the term "timber" means all types of species of wood and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood and plywood.
  • the method for treating timber according to the invention mainly consists in contacting one or more compounds according to the invention or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means.
  • Powdery mildew diseases such as :
  • Blumeria diseases caused for example by Blumeria graminis ;
  • Podosphaera diseases caused for example by Podosphaera leucotricha ;
  • Sphaerotheca diseases caused for example by Sphaerotheca fuliginea ;
  • Uncinula diseases caused for example by Uncinula necator ;
  • Gymnosporangium diseases caused for example by Gymnosporangium sabinae ;
  • Hemileia diseases caused for example by Hemileia vastatrix ;
  • Phakopsora diseases caused for example by Phakopsora pachyrhizior Phakopsora meibomiae ;
  • Puccinia diseases caused for example by Puccinia recondita ;
  • Uromyces diseases caused for example by Uromyces appendiculatus ;
  • Oomycete diseases such as :
  • Bremia diseases caused for example by Bremia lactucae ;
  • Peronospora diseases caused for example by Peronospora pisi or P. brassicae ;
  • Phytophthora diseases caused for example by Phytophthora infestans ;
  • Plasmopara diseases caused for example by Plasmopara viticola ;
  • Pseudoperonospora diseases caused for example by Pseudoperonospora humuli or
  • Pythium diseases caused for example by Pythium ultimum ;
  • Leafspot, leaf blotch and leaf blight diseases such as :
  • Alternaria diseases caused for example by Alternaria solani ;
  • Cercospora diseases caused for example by Cercospora beticola ;
  • Cladiosporum diseases caused for example by Cladiosporium cucumerinum ;
  • Cochliobolus diseases caused for example by Cochliobolus sativus ;
  • Colletotrichum diseases caused for example by Colletotrichum lindemuthanium ;
  • Cycloconium diseases caused for example by Cycloconium oleaginum ;
  • Diaporthe diseases caused for example by Diaporthe citri ;
  • Elsinoe diseases caused for example by Elsinoe fawcettii ;
  • Gloeosporium diseases caused for example by Gloeospohum laeticolor ;
  • Glomerella diseases caused for example by Glomerella cingulata ;
  • Guignardia diseases caused for example by Guignardia bidwelli ;
  • Leptosphaeria diseases caused for example by Leptosphaeha maculans ; Leptosphaeha nodorum ;
  • Magnaporthe diseases caused for example by Magnaporthe grisea ;
  • Mycosphaerella diseases caused for example by Mycosphaerella graminicola ; Mycosphaerella arachidicola ; Mycosphaerella fijiensis ;
  • Phaeosphaeria diseases caused for example by Phaeosphaeria nodorum ;
  • Pyrenophora diseases caused for example by Pyrenophora teres ;
  • Ramularia diseases caused for example by Ramularia collo-cygni ;
  • Rhynchosporium diseases caused for example by Rhynchosporium secalis ;
  • Septoria diseases caused for example by Septoria apii or Septoria lycopercisi ;
  • Typhula diseases caused for example by Typhula incarnata ;
  • Venturia diseases caused for example by Venturia inaequalis ;
  • Root and stem diseases such as :
  • Fusarium diseases caused for example by Fusarium oxysporum ;
  • Gaeumannomyces diseases caused for example by Gaeumannomyces graminis ;
  • Rhizoctonia diseases caused for example by Rhizoctonia solani ;
  • Tapesia diseases caused for example by Tapesia acuformis ;
  • Thielaviopsis diseases caused for example by Thielaviopsis basicola ;
  • Ear and panicle diseases such as :
  • Alternaria diseases caused for example by Alternaria spp. ;
  • Aspergillus diseases caused for example by Aspergillus flavus ;
  • Cladosporium diseases caused for example by Cladosporium spp. ;
  • Claviceps diseases caused for example by Claviceps purpurea ;
  • Fusarium diseases caused for example by Fusarium culmorum ;
  • Gibberella diseases caused for example by Gibberella zeae ;
  • Monographella diseases caused for example by Monographella nivalis ; Smut and bunt diseases such as :
  • Sphacelotheca diseases caused for example by Sphacelotheca reiliana ;
  • Tilletia diseases caused for example by Tilletia caries ;
  • Urocystis diseases caused for example by Urocystis occulta ;
  • Ustilago diseases caused for example by Ustilago nuda ;
  • Aspergillus diseases caused for example by Aspergillus flavus ;
  • Botrytis diseases caused for example by Botrytis cinerea ;
  • Penicillium diseases caused for example by Penicillium expansum ;
  • Sclerotinia diseases caused for example by Sclerotinia sclerotiorum ;
  • Verticilium diseases caused for example by Verticilium alboatrum ;
  • Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases :
  • Aphanomyces diseases caused for example by Aphanomyces euteiches Ascochyta diseases, caused for example by Ascochyta lentis
  • Cladosporium diseases caused for example by Cladosporium herbarum
  • Cochliobolus diseases caused for example by Cochliobolus sativus
  • Colletotrichum diseases caused for example by Colletotrichum coccodes
  • Fusarium diseases caused for example by Fusarium culmorum
  • Gibberella diseases caused for example by Gibberella zeae
  • Macrophomina diseases caused for example by Macrophomina phaseolina
  • Monographella diseases caused for example by Monographella nivalis
  • Penicillium diseases caused for example by Penicillium expansum
  • Phoma diseases caused for example by Phoma lingam
  • Phomopsis diseases caused for example by Phomopsis sojae
  • Phytophthora diseases caused for example by Phytophthora cactorum
  • Pyrenophora diseases caused for example by Pyrenophora graminea Pyricularia diseases, caused for example by Pyricularia oryzae;
  • Pythium diseases caused for example by Pythium ultimum
  • Rhizopus diseases caused for example by Rhizopus oryzae
  • Sclerotium diseases caused for example by Sclerotium rolfsii;
  • Typhula diseases caused for example by Typhula incarnata
  • Verticillium diseases caused for example by Verticillium dahliae ;
  • Canker, broom and dieback diseases such as : Nectria diseases, caused for example by Nectria galligena ;
  • Blight diseases such as :
  • Leaf blister or leaf curl diseases such as :
  • Taphrina diseases caused for example by Taphrina deformans ;
  • Esca diseases caused for example by Phaemoniella clamydospora ;
  • Eutypa dyeback caused for example by Eutypa lata ;
  • Botrytis diseases caused for example by Botrytis cinerea ;
  • Rhizoctonia diseases caused for example by Rhizoctonia solani
  • Helminthosporium diseases caused for example by Helminthosporium solani.
  • the treatment according to the invention may also result in superadditive
  • the active compound combinations according to the invention may also have a strengthening effect in plants.
  • Plant-strengthening (resistance-inducing) substances are to be understood as meaning, in the present context, those substances or combinations of substances which are capable of stimulating the defense system of plants in such a way that, when subsequently inoculated with unwanted phytopathogenic fungi and/ or microorganisms and/or viruses, the treated plants display a substantial degree of resistance to these unwanted phytopathogenic fungi and/ or microorganisms and/or viruses.
  • phytopathogenic fungi and/ or microorganisms and/or viruses are to be understood as meaning phytopathogenic fungi, bacteria and viruses.
  • the substances according to the invention can be employed for protecting plants against attack by the abovementioned pathogens within a certain period of time after the treatment.
  • the period of time within which protection is effected generally extends from 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds.
  • Plants and plant cultivars which are preferably to be treated according to the invention include all plants which have genetic material which impart particularly advantageous, useful traits to these plants (whether obtained by breeding and/or biotechnological means).
  • Plants and plant cultivars which are also preferably to be treated according to the invention are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
  • Plants and plant cultivars which may also be treated according to the invention are those plants which are resistant to one or more abiotic stresses.
  • Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozon exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
  • Plants and plant cultivars which may also be treated according to the invention are those plants characterized by enhanced yield characteristics. Increased yield in said plants can be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation.
  • Yield can furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance.
  • Further yield traits include seed composition, such as carbohydrate content, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
  • Plants that may be treated according to the invention are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stress factors. Such plants are typically made by crossing an inbred male-sterile parent line (the female parent) with another inbred male-fertile parent line (the male parent). Hybrid seed is typically harvested from the male sterile plants and sold to growers. Male sterile plants can sometimes (e.g. in corn) be produced by detasseling, i.e. the mechanical removal of the male reproductive organs (or males flowers) but, more typically, male sterility is the result of genetic determinants in the plant genome.
  • Male sterile plants can also be obtained by plant biotechnology methods such as genetic engineering.
  • a particularly useful means of obtaining male-sterile plants is described in WO 1989/10396 in which, for example, a ribonuclease such as barnase is selectively expressed in the tapetum cells in the stamens. Fertility can then be restored by expression in the tapetum cells of a ribonuclease inhibitor such as barstar (e.g. WO 1991/002069).
  • Plants or plant cultivars obtained by plant biotechnology methods such as genetic engineering which may be treated according to the invention are herbicide-tolerant plants, i.e. plants made tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation, or by selection of plants containing a mutation imparting such herbicide tolerance.
  • Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate oxido-reductase enzyme as described in US 5,776,760 and US 5,463,175.
  • Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate acetyl transferase enzyme as described in for example WO 2002/036782, WO 2003/092360, WO 2005/012515 and WO 2007/024782.
  • Glyphosate-tolerant plants can also be obtained by selecting plants containing naturally-occurring mutations of the above-mentioned genes, as described in for example WO 2001/024615 or WO 2003/013226.
  • herbicide resistant plants are for example plants that are made tolerant to herbicides inhibiting the enzyme glutamine synthase, such as bialaphos, phosphinothricin or glufosinate.
  • Such plants can be obtained by expressing an enzyme detoxifying the herbicide or a mutant glutamine synthase enzyme that is resistant to inhibition.
  • One such efficient detoxifying enzyme is an enzyme encoding a phosphinothricin acetyltransferase (such as the bar or pat protein from Streptomyces species). Plants expressing an exogenous phosphinothricin acetyltransferase are for example described in US 5,561 ,236; US 5,648,477;
  • hydroxyphenylpyruvatedioxygenase HPPD
  • Hydroxyphenylpyruvatedioxygenases are enzymes that catalyze the reaction in which para-hydroxyphenylpyruvate (HPP) is transformed into homogentisate.
  • Plants tolerant to HPPD-inhibitors can be transformed with a gene encoding a naturally-occurring resistant HPPD enzyme, or a gene encoding a mutated HPPD enzyme as described in WO 1996/038567, WO 1999/024585 and WO 1999/024586.
  • Tolerance to HPPD-inhibitors can also be obtained by transforming plants with genes encoding certain enzymes enabling the formation of homogentisate despite the inhibition of the native HPPD enzyme by the HPPD-inhibitor. Such plants and genes are described in WO 1999/034008 and WO 2002/36787. Tolerance of plants to HPPD inhibitors can also be improved by transforming plants with a gene encoding an enzyme prephenate dehydrogenase in addition to a gene encoding an HPPD-tolerant enzyme, as described in WO 2004/024928.
  • Still further herbicide resistant plants are plants that are made tolerant to acetolactate synthase (ALS) inhibitors.
  • ALS-inhibitors include, for example, sulfonylurea, imidazolinone, triazolopyrimidines, pyrimidinyloxy(thio)benzoates, and/or sulfonylaminocarbonyltriazolinone herbicides.
  • ALS enzyme also known as acetohydroxyacid synthase, AHAS
  • AHAS acetohydroxyacid synthase
  • imidazolinone-tolerant plants are also described in for example WO 2004/040012, WO 2004/106529, WO 2005/020673, WO 2005/093093, WO 2006/007373, WO 2006/015376, WO 2006/024351 , and WO 2006/060634. Further sulfonylurea- and imidazolinone-tolerant plants are also described in for example WO 2007/024782.
  • plants tolerant to imidazolinone and/or sulfonylurea can be obtained by induced mutagenesis, selection in cell cultures in the presence of the herbicide or mutation breeding as described for example for soybeans in US 5,084,082, for rice in WO 1997/41218, for sugar beet in US 5,773,702 and WO 1999/057965 , for lettuce in US 5,198,599, or for sunflower in WO 2001/065922.
  • Plants or plant cultivars obtained by plant biotechnology methods such as genetic engineering which may also be treated according to the invention are insect-resistant transgenic plants, i.e. plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such insect resistance.
  • An "insect-resistant transgenic plant”, as used herein, includes any plant containing at least one transgene comprising a coding sequence encoding:
  • an insecticidal crystal protein from Bacillus thuringiensis or an insecticidal portion thereof such as the insecticidal crystal proteins listed by Crickmore et al., Microbiology and Molecular Biology Reviews (1998), 62, 807-813, updated by Crickmore et al. (2005) at the Bacillus thuringiensis toxin nomenclature, online at:
  • insecticidal portions thereof e.g., proteins of the Cry protein classes CrylAb, CryiAc, Cry1 F, Cry2Ab, Cry3Aa, or Cry3Bb or insecticidal portions thereof; or
  • a hybrid insecticidal protein comprising parts of different insecticidal crystal proteins from Bacillus thuringiensis, such as a hybrid of the proteins of 1 ) above or a hybrid of the proteins of 2) above, e.g., the Cry1A.1O5 protein produced by corn event MON98034 (WO 2007/027777); or
  • VIP vegetative insecticidal
  • Plants or plant cultivars which may also be treated according to the invention are tolerant to abiotic stresses. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such stress resistance. Particularly useful stress tolerance plants include: a. plants which contain a transgene capable of reducing the expression and/or the activity of poly(ADP-ribose)polymerase (PARP) gene in the plant cells or plants as described in WO 2000/004173 or WO2006/045633 or PCT/EP07/004142. b.
  • PARP poly(ADP-ribose)polymerase
  • plants which contain a stress tolerance enhancing transgene capable of reducing the expression and/or the activity of the PARG encoding genes of the plants or plants cells as described e.g. in WO 2004/090140.
  • plants which contain a stress tolerance enhancing transgene coding for a plant- functional enzyme of the nicotinamide adenine dinucleotide salvage synthesis pathway including nicotinamidase, nicotinate phosphoribosyltransferase, nicotinic acid mononucleotide adenyl transferase, nicotinamide adenine dinucleotide synthetase or nicotine amide phosphoribosyltransferase as described e.g.
  • Plants or plant cultivars obtained by plant biotechnology methods such as genetic engineering which may also be treated according to the invention show altered quantity, quality and/or storage-stability of the harvested product and/or altered properties of specific ingredients of the harvested product such as :
  • transgenic plants which synthesize a modified starch, which in its physical-chemical characteristics, in particular the amylose content or the amylose/amylopectin ratio, the degree of branching, the average chain length, the side chain distribution, the viscosity behaviour, the gelling strength, the starch grain size and/or the starch grain morphology, is changed in comparison with the synthesised starch in wild type plant cells or plants, so that this is better suited for special applications.
  • a modified starch which in its physical-chemical characteristics, in particular the amylose content or the amylose/amylopectin ratio, the degree of branching, the average chain length, the side chain distribution, the viscosity behaviour, the gelling strength, the starch grain size and/or the starch grain morphology, is changed in comparison with the synthesised starch in wild type plant cells or plants, so that this is better suited for special applications.
  • transgenic plants synthesizing a modified starch are disclosed, for example, in EP 0571427, WO 1995/004826, EP 0719338, WO 1996/15248, WO 1996/19581 , WO 1996/27674, WO 1997/11188, WO 1997/26362, WO 1997/32985, WO
  • transgenic plants which synthesize non starch carbohydrate polymers or which synthesize non starch carbohydrate polymers with altered properties in comparison to wild type plants without genetic modification.
  • Examples are plants producing polyfructose, especially of the inulin and levan-type, as disclosed in EP 0663956, WO 1996/001904, WO 1996/021023, WO 1998/039460, and WO 1999/024593, plants producing alpha 1 ,4 glucans as disclosed in WO 1995/031553, US 2002/031826, US 6,284,479, US 5,712,107, WO 1997/047806, WO 1997/047807, WO
  • Plants or plant cultivars which can be obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants, such as cotton plants, with altered fiber characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered fiber characteristics and include: a) Plants, such as cotton plants, containing an altered form of cellulose synthase genes as described in WO 1998/000549
  • Plants such as cotton plants, having fibers with altered reactivity, e.g. through the expression of N-acteylglucosaminetransferase gene including nodC and chitinsynthase genes as described in WO2006/136351
  • Plants or plant cultivars which may also be treated according to the invention are plants, such as oilseed rape or related Brassica plants, with altered oil profile characteristics. Such plants can be obtained by genetic transformation or by selection of plants contain a mutation imparting such altered oil characteristics and include:
  • transgenic plants which may be treated according to the invention are plants which comprise one or more genes which encode one or more toxins, such as the following which are sold under the trade names YIELD GARD® (for example maize, cotton, soya beans), KnockOut® (for example maize), BiteGard® (for example maize), Bt-Xtra® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton), Nucotn 33B®(cotton), NatureGard® (for example maize), Protecta® and NewLeaf® (potato).
  • YIELD GARD® for example maize, cotton, soya beans
  • KnockOut® for example maize
  • BiteGard® for example maize
  • Bt-Xtra® for example maize
  • StarLink® for example maize
  • Bollgard® cotton
  • Nucotn® cotton
  • Nucotn 33B® cotton
  • NatureGard® for example maize
  • herbicide-tolerant plants examples include maize varieties, cotton varieties and soya bean varieties which are sold under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, for example maize).
  • Herbicide-resistant plants plants bred in a conventional manner for herbicide tolerance
  • Clearfield® for example maize.
  • Step 2 To 5ml of tetrahydrofuran were added3.5mg (0.01 mmol) of copper iodide, 143mg (1.49mnnol) of heptyne, 150mg (0.37mmol) of 5- ⁇ 2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1-naphthyl ⁇ -1-methyl-1 H-tetrazole (as obtained in step 1 ), 193mg (1.49mnnol) of N,N-diisopropylethylamine and 21.6mg (O.OI mmol) of tetrakis(triphenylphosphine)palladium(0) in a sealed tube under argon atmosphere. The reaction mixture was left to stand at room temperature overnight. Filtration on chemelut, and solvent evaporation of the filtatre were performed before the product was purified with HPLC.
  • table 1 A in (I) can have for example the values A1 , A2 and Z:
  • M+H means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass unit) respectively, as observed in mass spectroscopy and M (APCI+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionization in mass spectroscopy.
  • Emulsifier 1 part by weight of Alkylarylpolyglycolether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • Example 4 (80 %), 13 (95 %), 17 (95 %), 18 (80 %), 20 (80 %), 21 (95 %), 22 (70 %), 25 (70 %) and 28 (90 %).

Abstract

The present invention relates to hydroximoyl-heterocycle derivatives, their process of preparation, intermediate compounds for their preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.

Description

FUNGICIDE HETEROCYCLES DERIVATIVES
DESCRIPTION The present invention relates to aryloxyalkyl-heterocycle derivatives, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
In Japanese patent application n°2005-41793, there are disclosed certain naphtyl derivatives of the following chemical structure:
Figure imgf000002_0001
wherein Q can be selected in a list of 7 various heterocycle groups substituted by various carbonylaminoderivatives and A can be selected in a list of 7various 5-menbered heterocycle groups. The compounds disclosed in these two documents do not prove to provide a comparable utility than the compounds according to the invention.
It is always of high-interest in agriculture to use novel pesticide compounds in order to avoid or to control the development of resistant strains to the active ingredients. It is also of high-interest to use novel compounds being more active than those already known, with the aim of decreasing the amounts of active compound to be used, whilst at the same time maintaining effectiveness at least equivalent to the already known compounds. We have now found a new family of compounds which possess the above mentioned effects or advantages.
Accordingly, the present invention provides aryloxyalkyl-heterocycle derivatives of formula (I)
Figure imgf000002_0002
(I)
wherein
• Q1 represents N or CY3 ;
• Q2 represents N or CY4
• Y1, Y2, Y3 and Y4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, hydroxycarbonyl, C-ι-C8-alkoxycarbonyl, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde 0-(C1-C8- alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted d-C8-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non- substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbonyl, substituted or non-substituted N-(C1 -C8-alkoxy)-d -C8- alkanimidoyl, substituted or non-substituted N-(C1-C8-alkoxy)-C1-C8-halogenoalkanimidoyl having
1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbamoyl, substituted or non- substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non-substituted N-C1-C8- alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkylcarbonyloxy, substituted or non-substituted C1-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted C-i-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamoylamino, substituted or non- substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-C-i-Cs-alkylcarbamoylamino, substituted or non-substituted CIi-C1-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N- C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(C1-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-
C1-C8-alkyl-(di-C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl-(di- C-ι-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylaminocarbonyloxy, substituted or non-substituted di-d-Cs-alkylaminocarbonyloxy, substituted or non-substituted C-i-Cs-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8- alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyl, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C1 -C8-alkyl-C-ι -C8- alkoxycarbamothioyl, substituted or non-substituted Ci-C8-alkylthioylannino, substituted or non- substituted Ci-Cs-halogenoalkylthioylannino having 1 to 5 halogen atoms, substituted or non- substituted (C-i-Cs-alkyl-carbannothioyO-oxy, substituted or non-substituted substituted or non- substituted (di-C-i-Cs-alkyl-carbamothioyO-oxy, substituted or non-substituted Ci-C8-alkylsulphinyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonyl, substituted or non-substituted C1-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminosulfamoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted (C-i-Ce-alkoxyimino^C-i-Ce-alkyl, substituted or non-substituted (C1-C6- alkenyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted (C-i-Ce-alkynyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)- silyloxy, substituted or non-substituted C-ι-C8-alkylsulfenylamino, substituted or non-substituted C-i-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted
C-i-Cs-alkylsulphonylamino, substituted or non-substituted C-i-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxysulphonylamino, substituted or non-substituted C-ι-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl, substituted or non-substituted (C1-C6- alkylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkenylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]-[C-ι-C8]-alkyl, substituted or non-substituted [{C-rCs-alky^C-rCs-alkylcarbony^aminoJHC-rCsl-alkyl, substituted or non-substituted [{C-rCs-alky^arylcarbony^aminoJHC-rCsl-alkyl, substituted or non-substituted [(C-rCs-alkylcarbony^aminoHC-rCsl-alkyl , substituted or non-substituted heterocyclyl, substituted or non-substituted heterocyclyloxy, or
• when Y1 and Y2 together with the aromatic cycle to which they are attached do form a naphtyl, quinoleine or isoquinoleine, Y3 and Y4 are as defined above;
• n represents 1 , 2, 3 or 4 ;
• R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphanyl, substituted or non-substituted CrC8-halogeno alkylsulphanyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenylsulphanyl, substituted or non- substituted C2-C8-halogeno alkenylsulphanyl having 1 to 5 halogen atoms, substituted or non- substituted C3-C8-alkynylsulphenyl, substituted or non-substituted C3-C8-halogeno alkynylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogeno alkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenylsulphenyl, substituted or non-substituted C2-C8- halogeno alkenylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynylsulphenyl, substituted or non-substituted C3-C8-halogeno alkynylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted Ci-C8-halogeno alkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8- alkenylsulphinyl, substituted or non-substituted C2-C8-halogeno alkenylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynylsulphinyl, substituted or non- substituted C3-C8-halogenoalkynylsulphinyl having 1 to 5 halogen atoms,
• T represents a hydrogen or a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T1 to T32 :
Figure imgf000005_0001
Figure imgf000006_0001
wherein
• X1 to X4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(CrC8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-C-ι-C6-alkyl group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non- substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3- C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylannino, substituted or non- substituted di-C-i-Cs-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non- substituted d-Cs-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1- C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-
C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(C1-C8- alkoxy)-C-ι-C8-alkanimidoyl, substituted or non-substituted N-(C1 -C8-alkoxy)-d -C8- halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non- substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non- substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyloxy, substituted or non-substituted d-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted d-Cs-halogenoalkylcarbamoylannino having 1 to 5 halogen atoms, substituted or non-substituted di-d-Cs-alkylcarbamoylannino, substituted or non-substituted di-d-Cs-halogenoalkylcarbamoylannino having 1 to 5 halogen atoms , substituted or non-substituted N-C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N- C1-C8-alkyl-(C1-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-C1-C8-alkyl-(di-C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N- C1-C8-alkyl-(di-C1-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylaminocarbonyloxy, substituted or non-substituted CIi-C1-C8- alkylaminocarbonyloxy, substituted or non-substituted d-C8-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyl, substituted or non-substituted d-Cs-alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyll, substituted or non-substituted C1-C8- alkylthioylamino, substituted or non-substituted d-C8-halogenoalkylthioylannino having 1 to 5 halogen atoms, substituted or non-substituted (d-C8-alkyl-carbamothioyl)-oxy, substituted or non- substituted substituted or non-substituted (di-d-C8-alkyl-carbamothioyl)-oxy, substituted or non- substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted d-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkylsulphonyl, substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylaminosulfannoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfannoyl, substituted or non-substituted (Ci-C6- alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non- substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non- substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non- substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl- [C-ι-C8]-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)-silyloxy, substituted or non-substituted C-rCs-alkylsulfenylamino, substituted or non-substituted d-Cs-halogenoalkylsulphinylannino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonylamino, substituted or non-substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxysulphonylamino, substituted or non-substituted C1-C8- halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(Ci-C8- alkyl)-silyl, substituted or non-substituted (C-ι-C6-alkylideneamino)oxy, substituted or non- substituted (Ci-C6-alkenylideneamino)oxy, substituted or non-substituted (Ci-C6- alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy ;
• W1 independently represents a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted Ci-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted
C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci-C8- alkoxy)-Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-Cs-alkylcarbamoyl, substituted or non- substituted N-Ci-Cs-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-CrC8- alkyloxycarbamothioyll, substituted or non-substituted d-Cs-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbannothioyl, substituted or non-substituted CrC8- alkylsulphinyl, substituted or non-substituted CrC8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non-substituted CrC8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted CrC8- alkylaminosulfamoyl, substituted or non-substituted di-d-Cs-alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl ;
A is selected in the list consisting of A1 to A 1 16
Figure imgf000009_0001
Figure imgf000010_0001
Figure imgf000011_0001
Figure imgf000012_0001
Figure imgf000013_0001
wherein
• Z\ Z2, Z3, Z4 Z5, Z6, Z7, Z8 and Z9 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non-substituted N-C"rC8-alkyl-(C"rC8-alkylamino)- amino group, a substituted or non-substituted (hydroxyimino)-C-ι-C6-alkyl group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl- C3-C8-cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8- alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted C1-C8- alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted (Ci-C8-alkoxycarbonyl)amino, substituted or non- substituted (C3-C8-cycloalkoxycarbonyl)amino, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted (C2-C8- alkenyloxycarbonyl)amino, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non- substituted N-(Ci-C8-alkoxy)-Ci-C8-alkaninnidoyl, substituted or non-substituted N-(Ci -C8-alkoxy)- Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-Cs-alkylcarbamoyl, substituted or non- substituted N-Ci-Cs-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-Ci-C8-alkylcarbamoylamino, substituted or non-substituted di-Ci-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(di-Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8- alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamothioyl, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted Ci-C8- alkylthioylamino, substituted or non-substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted Ci-C8-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non- substituted (Ci-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non- substituted (di-Ci-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted Ci-C8- alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphinyl, substituted or non-substituted Ci-C8- halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkyl- sulphonyl, substituted or non-substituted Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8-alkylaminosulfamoyl, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted
(Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted (arylcarbonyl)amino, substituted or non-substituted (heterocyclylcarbonyl)amino, substituted or non-substituted (aryloxcarbonyl)amino, substituted or non-substituted (heterocyclyloxycarbony^amino, substituted or non-substituted tri(d-C8-alkyl)- silyloxy, substituted or non-substituted d-C8-alkylsulfenylamino, substituted or non-substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylsulphonylannino, substituted or non-substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkoxysulphonylamino, substituted or non-substituted d-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8-alkyl)-silyl, substituted or non-substituted (C1-C6- alkylideneamino)oxy, substituted or non-substituted (d-C6-alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy; provided that when T represents T28, T29, T31 or T32 and when Y1 and Y2 together with the aromatic cycle to which they are attached form a naphtyl and when A represents A2 , A6, A11, A12, A14, A15, A18, A25, A26, A29 or A31 then Z1 represents a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(d-C8-alkyl)oxime, a formyloxy group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted d-C8-alkoxyamino group, substituted or non-substituted N-d-C8-alkyl-(d-C8-alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non- substituted N-d-C8-alkyl-(d-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-d-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(d-C8-alkyl)silyl-d|-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbonyl, substituted or non-substituted N-(C1 -C8-alkoxy)-d -C8- alkanimidoyl, substituted or non-substituted N-(C1-C8-alkoxy)-C1-C8-halogenoalkanimidoyl having
1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non- substituted d-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylcarbonyloxy, substituted or non-substituted C1-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminocarbonyloxy, substituted or non-substituted di-C-i-Cs-alkylaminocarbonyloxy, substituted or non-substituted Ci-Cs-alkylcarbannothioyl, substituted or non-substituted di-Ci-C8- alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyl, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C1 -C8-alkyl-C-ι -C8- alkoxycarbamothioyl, substituted or non-substituted Ci-C8-alkylthioylannino, substituted or non- substituted (C-i-Cs-alkoxythiocarbony^annino, substituted or non-substituted C1-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (C1-C8- alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (CIi-C1-C8- alkyl-carbamothioyl)-oxy, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non- substituted C-i-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non- substituted C-rCs-alkylsulphinyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted CIi-C1-C8- alkylaminosulfamoyl, substituted or non-substituted (C-i-Ce-alkoxyimino^C-i-Cβ-alkyl, substituted or non-substituted (C-i-Ce-alkenyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (C1-C6- alkynyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted tri(C-ι-C8-alkyl)-silyloxy, substituted or non- substituted C-ι-C8-alkylsulfenylamino, substituted or non-substituted C1-C8- halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphonylamino, substituted or non-substituted C-rCs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxysulphonylamino, substituted or non-substituted C-ι-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl, substituted or non-substituted (C-ι-C6-alkylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkenylideneamino)oxy, substituted or non-substituted (C1-
C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy;;
• K1 and K2 independently represent a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non- substituted tri(C1-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted C1-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylannino, substituted or non-substituted di- d-Cs-alkylannino, substituted or non-substituted C-ι-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(C-ι-C8-alkoxy)-C-ι-C8-alkanimidoyl, substituted or non-substituted N-(C1-C8- alkoxy)-C-ι-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-C-i-Cs-alkylcarbamoyl, substituted or non- substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted C-i-Cs-alkoxycarbamoyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non- substituted C-i-Cs-alkoxycarbonyl, substituted or non-substituted C-rCs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyll, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted C1-C8- alkylsulphinyl, substituted or non-substituted C-i-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonyl, substituted or non-substituted C1-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminosulfamoyl, substituted or non-substituted di-C-ι-C8-alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl ;
• G1 and G2 are independently selected in the list consisting of oxygen, sulfur, NR3, N-OR4 and N-NR5R6 wherein R3 to R6 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8- alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted C-ι-C8-alkoxy, substituted or non-substituted C-ι-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl ; s salts, N-oxides, metallic complexes and metalloidic complexes thereof As a further aspect, when Y1 and Y2 together with the aromatic cycle to which they are attached in the compound of formula (I) do form a naphtyl, quinoleine or isoquinoleine, the present invention provides aryloxyalkyl-heterocycle derivatives of formula (Ia), (Ib) and (Ic)
Figure imgf000018_0001
(Ia) (Ib) (Ic)
wherein
• A, T, n, R1, R2, Y3 and Y4 are defined in the same manner as the corresponding substituents of the compounds of formula (I) according to the invention ;
• Y5 to Y8 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non- substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non-substituted C1- C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted Ci-C8- halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted Ci-C8- alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8- alkenyloxy, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted Ci-C8- alkylcarbonyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl;
Any of the compounds according to the invention can exist as one or more stereoisomers depending on the number of stereogenic units (as defined by the IUPAC rules) in the compound. The invention thus relates equally to all the stereoisomers and to the mixtures of all the possible stereoisomers, in all proportions. The stereoisomers can be separated according to the methods which are known per se by the man ordinary skilled in the art.
Notably, the stereostructure of the oxime moiety present in the tetrazolyloxime derivative of formula (I) includes (E) or (Z) isomers and these stereoisomers form part of the present invention.
According to the invention, the following generic terms are generally used with the following meanings:
• halogen means fluorine, chlorine, bromine or iodine ;
• heteroatom can be nitrogen, oxygen or sulphur ; • unless indicated otherwise, a group or a substituent that is substituted according to the invention can be substituted by one or more of the following groups or atoms: a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6- sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde 0-(Ci-C8- alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, a (hydroxyimino)-C-ι-C6-alkyl group, a C-ι-C8-alkyl, a tri(Ci-C8- alkyl)silyl, a tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, C3-C8-cycloalkyl, tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, a C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, a C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, a C3-C8-cycloalkenyl a C2-C8-alkynyl, a C2-C8-alkenyloxy, a C2- C8-alkynyloxy, a d-C8-alkylamino, a di-d-C8-alkylamino, a d-C8-alkoxy, a d-C8-halogenoalkoxy having 1 to 5 halogen atoms, a d-C8-alkylsulphenyl, a d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, a C2-C8-alkenyloxy, a C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, a C3-C8-alkynyloxy, a C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, a Ci-C8- alkylcarbonyl, a Ci-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, a Ci-C8- alkylcarbamoyl, a di-Ci-Cs-alkylcarbamoyl, a N-Ci-C8-alkyloxycarbamoyl, a Ci-C8- alkoxycarbamoyl, a N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, a Ci-C8-alkoxycarbonyl, a Ci-C8- halogenoalkoxycarbonyl having 1 to 5 halogen atoms, a Ci-Cs-alkylcarbonyloxy, a Ci-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, a Ci-Cs-alkylcarbonylamino, a Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkoxycarbonylamino, substituted or non-substituted Ci-C8-halogenoalkoxycarbonylamino having
1 to 5 halogen atoms, a Ci-C8-alkylaminocarbonyloxy, a di-Ci-C8-alkylaminocarbonyloxy, a Ci-C8- alkyloxycarbonyloxy, a Ci-C8-alkylsulphenyl, a Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, a Ci-C8-alkylsulphinyl, a Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, a Ci-C8-alkylsulphonyl, a Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, a Ci- C8-alkylaminosulfamoyl, a di-Ci-C8-alkylaminosulfamoyl, a (d-C6-alkoxyimino)-Ci-C6-alkyl, a (Ci-
C6-alkenyloxyimino)-Ci-C6-alkyl, a (d-C6-alkynyloxyimino)-Ci-C6-alkyl, (benzyloxyimino)-Ci-C6- alkyl, Ci-C8-alkoxyalkyl, Ci-C8-halogenoalkoxyalkyl having 1 to 5 halogen atoms, aryl, heterocyclyl, benzyloxy, benzylsulphenyl, benzylamino, phenoxy, phenylsulphenyl or phenylamino;
• the term "aryl" means phenyl or naphthyl;
• The term "heterocyclyl" means saturated or unsaturated A-, 5-, 6- or 7-membered ring comprising up to 4 heteroatoms selected in the list consisting of N, O, S.
Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Y1, Y2, Y3 and Y4 independently represent a hydrogen atom, a halogen atom, a cyano group, a substituted or non- substituted carbaldehyde O-(Ci-C8-alkyl)oxime, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl.
More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Y1, Y2, Y3 and Y4 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkoxy.
Even more preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Y1, Y2, Y3 and Y4 independently represent a hydrogen atom or a fluorine atom.
Other preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein n represents 1.
Other preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein R1 and R2 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted C1-C8- alkyl.
More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein R1 and R2 independently represent a hydrogen atom. Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T27 to T32.
More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T31 tO T32.
Even more preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein T represents T31.
Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X1 to X4 independently represent a hydrogen atom, a halogen atom, a substituted or non-substituted carbaldehyde
O-(Ci-C8-alkyl)oxime, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms.
More preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X1 to X4 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C8-alkyl. Even more preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein X1 to X4 independently represent a methyl group.
Preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein W1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non- substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, substituted or non- substituted aryl-[Ci-C8]-alkyl.
Other more preferred compounds of formula (I) and (Ia) to (lc)according to the invention are those wherein W1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy and cyano. Other preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein A is selected in the list consisting of A1 to A58.
Other more preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein A is selected in the list consisting of A2, A6, A8, A11 to A18. Other preferred compounds of formula (I) and (Ia) to (Ic) according to the invention are those wherein Z1 represents a hydrogen atom, a halogen atom, an amino group, a formylamino group, substituted or non- substituted Ci-C8-alkoxyamino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted Ci-C8-alkyl, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non-substituted CIi-C1-C8- alkylamino, substituted or non-substituted (d-C8-alkoxycarbonyl)amino, substituted or non-substituted (C3-C8-cycloalkoxycarbonyl)amino, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)annino, substituted or non-substituted C1-C8- alkylcarbonyl, substituted or non-substituted d-Cs-alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted d-C8-alkylthioylannino, substituted or non- substituted (d-C8-alkoxythiocarbonyl)annino, substituted or non-substituted C1-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted benzylamino, substituted or non-substituted phenylamino, substituted or non-substituted (arylcarbonyl)amino, substituted or non-substituted (heterocyclylcarbonyl)amino, substituted or non-substituted (aryloxcarbonyl)amino, substituted or non-substituted (heterocyclyloxycarbonyl)amino.
Other more preferred compounds of formula (I) and (Ia) to (lc)according to the invention are those wherein Z1 represents an amino group, a halogen atom, a formylamino group, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylannino, substituted or non-substituted (Ci-C8-alkoxycarbonyl)annino, substituted or non-substituted (C3-C8-cycloalkoxycarbonyl)annino, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)annino, substituted or non-substituted (C3-C8- alkynyloxycarbonyl)amino, substituted or non-substituted d-Cs-alkylcarbonylannino, substituted or non- substituted (arylcarbonyl)amino, substituted or non-substituted (heterocyclylcarbony^amino, substituted or non-substituted (aryloxycarbonyl)amino, substituted or non-substituted (heterocyclyloxycarbony^amino. Other preferred compounds of formula (I) and (Ia) to (lc)according to the invention are those wherein Z2 to Z9 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non- substituted d-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted C1- C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl.
Other more preferred compounds of formula (I) and (Ia) to (lc)according to the invention are those wherein Z2 to Z9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
Other preferred compounds of formula (I) and (Ia) to (lc)according to the invention are those wherein K1 and K2 are independently selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
Preferred compounds of formula (Ia) to (Ic) according to the invention are those wherein Y5 to Y8 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C8-alkyl. More preferred compounds of formula (Ia) to (Ic) according to the invention are those wherein Y5 to Y8 independently represent a hydrogen atom or a fluorine atom.
The above mentioned preferences with regard to the substituents of the of formula (I) and (Ia) to (Ic) according to the invention can be combined in various manners. These combinations of preferred features thus provide sub-classes of compounds according to the invention. Examples of such sub-classes of preferred compounds according to the invention can combine:
preferred features of A with preferred features of one or more of T, Q1 , Q2, Y1 , Y2, R1 , R2 and n ; preferred features of T with preferred features of one or more of A, Q1, Q2, Y1, Y2, R1, R2 and n ; preferred features Q1 with preferred features of one or more of A, T, Q2, Y1, Y2, R1, R2 and n ; - preferred features Q2 with preferred features of one or more of A, T, Q1, Y1, Y2, R1, R2 and n ; preferred features Y1 with preferred features of one or more of A, T, Q1, Q2, Y2, R1, R2 and n ; preferred features Y2 with preferred features of one or more of A, T, Q1, Q2, Y1, R1, R2 and n ; preferred features R1 with preferred features of one or more of A, T, Q1, Q2, Y1, Y2, R2 and n ; preferred features R2 with preferred features of one or more of A, T, Q1, Q2, Y1, Y2, R1 and n ; preferred features n with preferred features of one or more of A, T, Q1, Q2, Y1, Y2, R1 and R2. In these combinations of preferred features of the substituents of the compounds according to the invention, the said preferred features can also be selected among the more preferred features of each of A, T, Q1, Q2, Y1, Y2, R1, R2 and n ; so as to form most preferred subclasses of compounds according to the invention.
The preferred features of the other substituents of the compounds according to the invention can also be part of such sub-classes of preferred compounds according to the invention, notably the groups of substituents X1 to X4, Z1 to Z9, K1, K2, G1, G2, Y3 to Y8 and W1.
The present invention also relates to a process for the preparation of compounds of formula (I) and (Ia) to (Ic). Thus, according to a further aspect of the present invention, there is a provided a process P1 for the preparation of compounds of formula (I) and (Ia) to (Ic), as herein-defined, as illustrated by the following reaction schemes.
Figure imgf000023_0001
(H) (Hi) (I)
Process P1
wherein T, A, Q1, Q2, Y1, Y2, R1, R2 and n are as herein-defined and LG represents a leaving group. Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as triflate, mesylate, or tosylate.
In a further aspect, the present invention also relates to a fungicide composition comprising an effective and non-phytotoxic amount of an active compound of formula (I).
The expression "effective and non-phytotoxic amount" means an amount of composition according to the invention which is sufficient to control or destroy the fungi present or liable to appear on the crops and which does not entail any appreciable symptom of phytotoxicity for the said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the climatic conditions and the compounds included in the fungicide composition according to the invention. This amount can be determined by systematic field trials, which are within the capabilities of a person skilled in the art. Thus, according to the invention, there is provided a fungicide composition comprising, as an active ingredient, an effective amount of a compound of formula (I) as herein defined and an agriculturally acceptable support, carrier or filler. According to the invention, the term "support" denotes a natural or synthetic organic or inorganic compound with which the active compound of formula (I) is combined or associated to make it easier to apply, notably to the parts of the plant. This support is thus generally inert and should be agriculturally acceptable. The support can be a solid or a liquid. Examples of suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports can also be used.
The composition according to the invention can also comprise additional components. In particular, the composition can further comprise a surfactant. The surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants. Mention can be made, for example, of polyacrylic acid salts, lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (in particular alkylphenols or arylphenols), salts of sulphosuccinic acid esters, taurine derivatives (in particular alkyl taurates), phosphoric esters of polyoxyethylated alcohols or phenols, fatty acid esters of polyols and derivatives of the above compounds containing sulphate, sulphonate and phosphate functions. The presence of at least one surfactant is generally essential if the active compound and/or the inert support are water-insoluble and if the vector agent for the application is water. Preferably, surfactant content can be comprised from 5% to 40% by weight of the composition.
Optionally, additional components can also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents. More generally, the active compounds can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
In general, the composition according to the invention can contain from 0.05 to 99% by weight of active compound, preferably 10 to 70% by weight.
Compositions according to the invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsifiable concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure),gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ULV) liquid, ultra low volume (ULV) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water soluble powder for seed treatment and wettable powder. These compositions include not only compositions which are ready to be applied to the plant or seed to be treated by means of a suitable device, such as a spraying or dusting device, but also concentrated commercial compositions which must be diluted before application to the crop.
The compounds according to the invention can also be mixed with one or more insecticide, fungicide, bactericide, attractant, acaricide or pheromone active substance or other compounds with biological activity. The mixtures thus obtained have a broadened spectrum of activity. The mixtures with other fungicide compounds are particularly advantageous. The composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound can also be particularly advantageous.
Examples of suitable fungicide mixing partners can be selected in the following lists:
(1 ) Inhibitors of the ergosterol biosynthesis, for example (1.1 ) aldimorph (1704-28-5), (1.2) azaconazole (60207-31-0), (1.3) bitertanol (55179-31-2), (1.4) bromuconazole (1 16255-48-2), (1.5) cyproconazole (113096-99-4), (1.6) diclobutrazole (75736-33-3), (1.7) difenoconazole (119446-68-3), (1.8) diniconazole (83657-24-3), (1.9) diniconazole-M (83657-18-5), (1.10) dodemorph (1593-77-7), (1.11 ) dodemorph acetate (31717-87-0), (1.12) epoxiconazole (106325-08-0), (1.13) etaconazole (60207-93-4), (1.14) fenarimol (60168-88-9), (1.15) fenbuconazole (114369-43-6), (1.16) fenhexamid (126833-17-8), (1.17) fenpropidin (67306-00-7), (1.18) fenpropimorph (67306-03-0), (1.19) fluquinconazole (136426-54-5), (1.20) flurprimidol (56425-91-3), (1.21 ) flusilazole (85509-19-9), (1.22) flutriafol (76674-21-0), (1.23) furconazole (112839-33-5), (1.24) furconazole-cis (112839-32-4), (1.25) hexaconazole (79983-71-4), (1.26) imazalil (60534-80-7), (1.27) imazalil sulfate (58594-72-2), (1.28) imibenconazole (86598-92-7), (1.29) ipconazole (125225-28-7), (1.30) metconazole (125116-23-6), (1.31 ) myclobutanil (88671-89-0), (1.32) naftifine (65472-88-0), (1.33) nuarimol (63284-71-9), (1.34) oxpoconazole (174212-12-5), (1.35) paclobutrazol (76738-62-0), (1.36) pefurazoate (101903-30-4), (1.37) penconazole (66246-88-6), (1.38) piperalin (3478-94-2), (1.39) prochloraz (67747-09-5), (1.40) propiconazole (60207-90-1 ), (1.41 ) prothioconazole (178928-70-6), (1.42) pyributicarb (88678-67-5), (1.43) pyrifenox (88283-41-4), (1.44) quinconazole (103970-75-8), (1.45) simeconazole (149508-90-7), (1.46) spiroxamine (118134-30-8), (1.47) tebuconazole (107534-96-3), (1.48) terbinafine (91 161-71-6), (1.49) tetraconazole (112281-77-3), (1.50) triadimefon (43121-43-3), (1.51 ) triadimenol (89482-17-7), (1.52) tridemorph (81412-43-3), (1.53) triflumizole (68694-11-1 ), (1.54) triforine (26644-46-2), (1.55) triticonazole (131983-72-7), (1.56) uniconazole (83657-22-1 ), (1.57) uniconazole-p (83657-17-4), (1.58) viniconazole (77174-66-4), (1.59) voriconazole (137234-62-9), (1.60) i-^-chlorophenyl^-O H-i ^^-triazol-i-yOcycloheptanol (129586-32- 9), (1.61 ) methyl 1-(2,2-dimethyl-2,3-dihydro-1 H-inden-1-yl)-1 H-imidazole-5-carboxylate (110323-95-0), (1.62) N'-{5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N- methylimidoformamide, (1.63) N-ethyl-N-methyl-N'-{2-methyl-5-(trifluoromethyl)-4-[3- (trimethylsilyl)propoxy]phenyl}imidoformamide and (1.64) O-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2- yl] 1 H-imidazole-1-carbothioate (11 1226-71-2).
(2) inhibitors of the respiratory chain at complex I or II, for example (2.1 ) bixafen (581809-46-3), (2.2) boscalid (188425-85-6), (2.3) carboxin (5234-68-4), (2.4) diflumetorim (130339-07-0), (2.5) fenfuram
(24691-80-3), (2.6) fluopyram (658066-35-4), (2.7) flutolanil (66332-96-5), (2.8) fluxapyroxad (907204-31- 3), (2.9) furametpyr (123572-88-3), (2.10) furmecyclox (60568-05-0), (2.11 ) isopyrazam (mixture of syn- epimeric racemate 1 RS, 4SR, 9RS and anti-epimeric racemate 1 RS,4SR,9SR) (881685-58-1 ), (2.12) isopyrazam (anti-epimeric racemate 1 RS, 4SR, 9SR), (2.13) isopyrazam (anti-epimeric enantiomer 1 R,4S,9S), (2.14) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.15) isopyrazam (syn epimeric racemate 1 RS, 4SR, 9RS), (2.16) isopyrazam (syn-epimeric enantiomer 1 R,4S,9R), (2.17) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.18) mepronil (55814-41-0), (2.19) oxycarboxin (5259-88-1 ), (2.20) penflufen (494793-67-8), (2.21 ) penthiopyrad (183675-82-3), (2.22) sedaxane (874967-67-6), (2.23) thifluzamide (130000-40-7), (2.24) 1-methyl-N-[2-(1 ,1 ,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1 H- pyrazole-4-carboxamide, (2.25) 3-(difluoromethyl)-1-methyl-N-[2-(1 ,1 ,2,2-tetrafluoroethoxy)phenyl]-1 H- pyrazole-4-carboxamide, (2.26) 3-(difluoromethyl)-N-[4-fluoro-2-(1 ,1 , 2,3,3, 3-hexafluoropropoxy)phenyl]-1- methyl-1 H-pyrazole-4-carboxamide, (2.27) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-
(difluoromethyl)-1-methyl-1 H-pyrazole-4-carboxamide (1092400-95-7) (WO 2008148570) and salts thereof.
(3) inhibitors of the respiratory chain at complex III, for example (3.1 ) ametoctradin (865318-97-4), (3.2) amisulbrom (348635-87-0), (3.3) azoxystrobin (131860-33-8), (3.4) cyazofamid (120116-88-3), (3.5) dimoxystrobin (141600-52-4), (3.6) enestroburin (238410-11-2) (WO 2004/058723), (3.7) famoxadone (131807-57-3) (WO 2004/058723), (3.8) fenamidone (161326-34-7) (WO 2004/058723), (3.9) fluoxastrobin (361377-29-9) (WO 2004/058723), (3.10) kresoxim-methyl (143390-89-0) (WO 2004/058723), (3.11 ) metominostrobin (133408-50-1 ) (WO 2004/058723), (3.12) orysastrobin (189892- 69-1 ) (WO 2004/058723), (3.13) picoxystrobin (117428-22-5) (WO 2004/058723), (3.14) pyraclostrobin (175013-18-0) (WO 2004/058723), (3.15) pyrametostrobin (915410-70-7) (WO 2004/058723), (3.16) pyraoxystrobin (862588-11-2) (WO 2004/058723), (3.17) pyribencarb (799247-52-2) (WO 2004/058723), (3.18) trifloxystrobin (141517-21-7) (WO 2004/058723), (3.19) (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5- fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide (WO 2004/058723), (3.20) (2E)-2- (methoxyimino)-N-methyl-2-(2-{[({(1 E)-1-[3-
(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide (WO 2004/058723) and salts thereof., (3.21 ) (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3- (trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide (158169-73-4), (3.22) (2E)-2-{2-[({[(1 E)-1- (3-{[(E)-1-fluoro-2-phenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N- methylethanamide (326896-28-0), (3.23) (2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2- ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide, (3.24) 2-chloro-N-(1 ,1 ,3- trimethyl-2,3-dihydro-1 H-inden-4-yl)pyridine-3-carboxamide (119899-14-8), (3.25) 5-methoxy-2-methyl-4- (2-{[({(1 E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1 ,2,4-triazol-3- one, (3.26) methyl (2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)innino]nnethyl}sulfanyl)nnethyl]phenyl}-3- methoxyprop-2-enoate (149601-03-6), (3.27) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2- hydroxybenzamide (226551-21-9), (3.28) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide (173662-97-0), (3.29) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide (394657-24-0) and salts thereof.
(4) Inhibitors of the mitosis and cell division, for example (4.1 ) benomyl (17804-35-2), (4.2) carbendazim (10605-21-7), (4.3) chlorfenazole (3574-96-7), (4.4) diethofencarb (87130-20-9), (4.5) ethaboxam (162650-77-3), (4.6) fluopicolide (239110-15-7), (4.7) fuberidazole (3878-19-1 ), (4.8) pencycuron (66063- 05-6), (4.9) thiabendazole (148-79-8), (4.10) thiophanate-methyl (23564-05-8), (4.11 ) thiophanate (23564- 06-9), (4.12) zoxamide (156052-68-5), (4.13) 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6- trifluorophenyl)[1 ,2,4]triazolo[1 ,5-a]pyrimidine (214706-53-3), (4.14) 3-chloro-5-(6-chloropyridin-3-yl)-6- methyl-4-(2,4,6-trifluorophenyl)pyridazine (1002756-87-7) and salts thereof.
(5) Compounds capable to have a multisite action, like for example (5.1 ) bordeaux mixture (8011-63-0), (5.2) captafol (2425-06-1 ), (5.3) captan (133-06-2) (WO 02/12172), (5.4) chlorothalonil (1897-45-6), (5.5) copper hydroxide (20427-59-2), (5.6) copper naphthenate (1338-02-9), (5.7) copper oxide (1317-39-1 ), (5.8) copper oxychloride (1332-40-7), (5.9) copper(2+) sulfate (7758-98-7), (5.10) dichlofluanid (1085-98- 9), (5.11 ) dithianon (3347-22-6), (5.12) dodine (2439-10-3), (5.13) dodine free base, (5.14) ferbam (14484-64-1 ), (5.15) fluorofolpet (719-96-0), (5.16) folpet (133-07-3), (5.17) guazatine (108173-90-6), (5.18) guazatine acetate, (5.19) iminoctadine (13516-27-3), (5.20) iminoctadine albesilate (169202-06-6), (5.21 ) iminoctadine triacetate (57520-17-9), (5.22) mancopper (53988-93-5), (5.23) mancozeb (8018-01- 7), (5.24) maneb (12427-38-2), (5.25) metiram (9006-42-2), (5.26) metiram zinc (9006-42-2), (5.27) oxine- copper (10380-28-6), (5.28) propamidine (104-32-5), (5.29) propineb (12071-83-9), (5.30) sulphur and sulphur preparations including calcium polysulphide (7704-34-9), (5.31 ) thiram (137-26-8), (5.32) tolylfluanid (731-27-1 ), (5.33) zineb (12122-67-7), (5.34) ziram (137-30-4) and salts thereof.
(6) Compounds capable to induce a host defence, like for example (6.1 ) acibenzolar-S-methyl (135158- 54-2), (6.2) isotianil (224049-04-1 ), (6.3) probenazole (27605-76-1 ), (6.4) tiadinil (223580-51-6) and salts thereof.
(7) Inhibitors of the amino acid and/or protein biosynthesis, for example , (7.1 ) andoprim (23951-85-1 ), (7.2) blasticidin-S (2079-00-7), (7.3) cyprodinil (121552-61-2), (7.4) kasugamycin (6980-18-3), (7.5) kasugamycin hydrochloride hydrate (19408-46-9), (7.6) mepanipyrim (110235-47-7), (7.7) pyrimethanil (53112-28-0) and salts thereof. (8) Inhibitors of the ATP production, for example (8.1 ) fentin acetate (900-95-8), (8.2) fentin chloride (639- 58-7), (8.3) fentin hydroxide (76-87-9) and (8.4) silthiofam (175217-20-6).
(9) Inhibitors of the cell wall synthesis, for example (9.1 ) benthiavalicarb (177406-68-7), (9.2) dimethomorph (110488-70-5), (9.3) flumorph (21 1867-47-9), (9.4) iprovalicarb (140923-17-7), (9.5) mandipropamid (374726-62-2), (9.6) polyoxins (1 1113-80-7), (9.7) polyoxorim (22976-86-9), (9.8) validamycin A (37248-47-8) and (9.9) valifenalate (283159-94-4; 283159-90-0).
(10) Inhibitors of the lipid and membrane synthesis, for example (10.1 ) biphenyl (92-52-4), (10.2) chloroneb (2675-77-6), (10.3) dicloran (99-30-9), (10.4) edifenphos (17109-49-8), (10.5) etridiazole (2593-
15-9), (10.6) iodocarb (55406-53-6), (10.7) iprobenfos (26087-47-8), (10.8) isoprothiolane (50512-35-1 ), (10.9) propamocarb (25606-41-1 ), (10.10) propamocarb hydrochloride (25606-41-1 ), (10.11 ) prothiocarb (19622-08-3), (10.12) pyrazophos (13457-18-6), (10.13) quintozene (82-68-8), (10.14) tecnazene (117-18- 0) and (10.15) tolclofos-m ethyl (57018-04-9).
(11 ) Inhibitors of the melanine biosynthesis, for example (11.1 ) carpropamid (104030-54-8), (11.2) diclocymet (139920-32-4), (11.3) fenoxanil (115852-48-7), (11.4) phthalide (27355-22-2), (11.5) pyroquilon (57369-32-1 ) and (11.6) tricyclazole (41814-78-2). (12) Inhibitors of the nucleic acid synthesis, for example (12.1 ) benalaxyl (71626-11-4), (12.2) benalaxyl-M (kiralaxyl) (98243-83-5), (12.3) bupirimate (41483-43-6), (12.4) clozylacon (67932-85-8), (12.5) dimethirimol (5221-53-4), (12.6) ethirimol (23947-60-6), (12.7) furalaxyl (57646-30-7), (12.8) hymexazol (10004-44-1 ), (12.9) metalaxyl (57837-19-1 ), (12.10) metalaxyl-M (mefenoxam) (70630-17-0), (12.11 ) ofurace (58810-48-3), (12.12) oxadixyl (77732-09-3) and (12.13) oxolinic acid (14698-29-4).
(13) Inhibitors of the signal transduction, for example (13.1 ) chlozolinate (84332-86-5), (13.2) fenpiclonil (74738-17-3), (13.3) fludioxonil (131341-86-1 ), (13.4) iprodione (36734-19-7), (13.5) procymidone (32809- 16-8), (13.6) quinoxyfen (124495-18-7) and (13.7) vinclozolin (50471-44-8). (14) Compounds capable to act as an uncoupler, like for example (14.1 ) binapacryl (485-31-4), (14.2) dinocap (131-72-6), (14.3) ferimzone (89269-64-7), (14.4) fluazinam (79622-59-6) and (14.5) meptyldinocap (131-72-6).
(15) Further compounds, like for example (15.1 ) benthiazole (21564-17-0), (15.2) bethoxazin (163269-30- 5), (15.3) capsimycin (70694-08-5), (15.4) carvone (99-49-0), (15.5) chinomethionat (2439-01-2), (15.6) chlazafenone (688046-61-9), (15.7) cufraneb (1 1096-18-7), (15.8) cyflufenamid (180409-60-3), (15.9) cymoxanil (57966-95-7), (15.10) cyprosulfamide (221667-31-8), (15.11 ) dazomet (533-74-4), (15.12) debacarb (62732-91-6), (15.13) dichlorophen (97-23-4), (15.14) diclomezine (62865-36-5), (15.15) difenzoquat (49866-87-7), (15.16) difenzoquat methylsulphate (43222-48-6), (15.17) diphenylamine (122- 39-4), (15.18) ecomate, (15.19) fenpyrazamine (473798-59-3), (15.20) flumetover (154025-04-4), (15.21 ) fluoroimide (41205-21-4), (15.22) flusulfamide (106917-52-6), (15.23) flutianil (304900-25-2), (15.24) fosetyl-aluminium (39148-24-8), (15.25) fosetyl-calcium, (15.26) fosetyl-sodium (39148-16-8), (15.27) hexachlorobenzene (118-74-1 ), (15.28) irumamycin (81604-73-1 ), (15.29) methasulfocarb (66952-49-6), (15.30) methyl isothiocyanate (556-61-6), (15.31 ) metrafenone (220899-03-6), (15.32) mildiomycin (67527-71-3), (15.33) natamycin (7681-93-8), (15.34) nickel dimethyldithiocarbamate (15521-65-0), (15.35) nitrothal-isopropyl (10552-74-6), (15.36) octhilinone (26530-20-1 ), (15.37) oxamocarb (917242-12- 7), (15.38) oxyfenthiin (34407-87-9), (15.39) pentachlorophenol and salts (87-86-5), (15.40) phenothrin, (15.41 ) phosphorous acid and its salts (13598-36-2), (15.42) propamocarb-fosetylate, (15.43) propanosine-sodium (88498-02-6), (15.44) proquinazid (189278-12-4), (15.45) pyrrolnitrine (1018-71-9) (EP-A 1 559 320), (15.46) tebufloquin (376645-78-2), (15.47) tecloftalam (76280-91-6), (15.48) tolnifanide (304911-98-6), (15.49) triazoxide (72459-58-6), (15.50) trichlamide (70193-21-4), (15.51 ) zarilamid (84527-51-5), (15.52) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3-thiazol-2- yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]ethanone (1003319-79-6) (WO
2008013622), (15.53) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3-thiazol-2- yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]ethanone (1003319-80-9) (WO
2008013622), (15.54) 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3-thiazol-2-yl}piperidin- 1-yl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]ethanone (1003318-67-9) (WO 2008013622), (15.55) 1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl 1 H-imidazole-1-carboxylate (11 1227-17-9), (15.56) 2,3,5,6- tetrachloro-4-(methylsulfonyl)pyridine (13108-52-6), (15.57) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin- 4(3H)-one (221451-58-7), (15.58) 2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl- 4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3-thiazol-2-yl}piperidin-1-yl)ethanone (1003316-53-7) (WO 2008013622), (15.59) 2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1 ,2-oxazol-3-yl]- 1 ,3-thiazol-2-yl}piperidin-1-yl)ethanone (1003316-54-8) (WO 2008013622), (15.60) 2-[5-methyl-3- (trifluoromethyl)-1 H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1 ,2-oxazol-3-yl)-1 ,3-thiazol-2-yl]piperidin-1- yl}ethanone (1003316-51-5) (WO 2008013622), (15.61 ) 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, (15.62) 2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1 H-imidazol-5-yl]pyridine, (15.63) 2-phenylphenol and salts (90-43-7), (15.64) 3,4,5-trichloropyridine-2,6-dicarbonitrile (17824-85-0), (15.65) 3-[5-(4-chlorophenyl)-2,3-dimethyl-1 ,2-oxazolidin-3-yl]pyridine, (15.66) 3-chloro-5-(4-chlorophenyl)-4-(2,6- difluorophenyl)-6-methylpyridazine, (15.67) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6- dimethylpyridazine, (15.68) 5-amino-1 ,3,4-thiadiazole-2-thiol, (15.69) 5-chloro-N'-phenyl-N'-(prc>p-2-yn-1- yl)thiophene-2-sulfonohydrazide (134-31-6), (15.70) 5-methyl-6-octyl[1 ,2,4]triazolo[1 ,5-a]pyrimidin-7- amine, (15.71 ) ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate, (15.72) N-(4-chlorobenzyl)-3-[3- methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanannide, (15.73) N-[(4-chlorophenyl)(cyano)methyl]-3-[3- methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanannide, (15.74) N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4- dichloropyridine-3-carboxamide, (15.75) N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3- carboxamide, (15.76) N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxannide, (15.77) N-{(E)-[(cyclopropylnnethoxy)innino][6-(difluoronnethoxy)-2,3-difluorophenyl]nnethyl}-2- phenylacetamide (221201-92-9), (15.78) N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3- difluorophenyl]methyl}-2-phenylacetamide (221201-92-9), (15.79) N-methyl-2-(1-{[5-methyl-3- (trifluoromethyl)-1 H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1 ,2,3,4-tetrahydronaphthalen-1-yl)-1 ,3-thiazole-4- carboxamide (922514-49-6) (WO 2007014290), (15.80) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1 H- pyrazol-i-yllacetylJpiperidin^-yO-N-^I R^I ^.S^-tetrahydronaphthalen-i-yll-I .S-thiazole^-carboxannide (922514-07-6) (WO 2007014290), (15.81 ) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1- yljacetylJpiperidin^-y^-N-^IS^I ^.S^-tetrahydronaphthalen-i-yll-I .S-thiazole^-carboxannide (922514- 48-5) (WO 2007014290), (15.82) pentyl {6-[({[( 1-m ethyl- 1 H-tetrazol-5- yl)(phenyl)methylidene]annino}oxy)nnethyl]pyridin-2-yl}carbannate, (15.83) phenazine-1-carboxylic acid, (15.84) quinolin-8-ol (134-31-6) and (15.85) quinolin-8-ol sulfate (2:1 ) (134-31-6).
According to another object of the present invention, there is provided a method for controlling the phytopathogenic fungi of plants, crops or seeds, characterized in that an agronomically effective and substantially non-phytotoxic quantity of a fungicide composition according to the invention is applied as seed treatment, foliar application, stem application, drench or drip application (chemigation) to the seed, the plant or to the fruit of the plant or to soil or to inert substrate (e.g. inorganic substrates like sand, rockwool, glasswool; expanded minerals like perlite, vermiculite, zeolite or expanded clay), Pumice, Pyroclastic materials or stuff, synthetic organic substrates (e.g. polyurethane) organic substrates (e.g. peat, composts, tree waste products like coir, wood fibre or chips, tree bark) or to a liquid substrate (e.g. floating hydroponic systems, Nutrient Film Technique, Aeroponics) wherein the plant is growing or wherein it is desired to grow.
The expression "are applied to the plants to be treated" is understood to mean, for the purposes of the present invention, that the fungicide composition which is the subject of the invention can be applied by means of various methods of treatment such as:
• spraying onto the aerial parts of the said plants a liquid comprising one of the said compositions,
• dusting, the incorporation into the soil of granules or powders, spraying, around the said plants and in the case of trees injection or daubing,
• coating or film-coating the seeds of the said plants with the aid of a plant-protection mixture comprising one of the said compositions.
The method according to the invention can either be a curing, preventing or eradicating method.
In this method, a composition used can be prepared beforehand by mixing the two or more active compounds according to the invention. According to an alternative of such a method, it is also possible to apply simultaneously, successively or separately compounds (A) and (B) so as to have the conjugated (A)/(B) effects, of distinct compositions each containing one of the two or three active ingredients (A) or (B). The dose of active compound usually applied in the method of treatment according to the invention is generally and advantageously
• for foliar treatments: from 0.1 to 10,000 g/ha, preferably from 10 to 1 ,000 g/ha, more preferably from 50 to 300g/ha; in case of drench or drip application, the dose can even be reduced, especially while using inert substrates like rockwool or perlite;
« for seed treatment: from 2 to 200 g per 100 kilogram of seed, preferably from 3 to 150 g per 100 kilogram of seed;
• for soil treatment: from 0.1 to 10,000 g/ha, preferably from 1 to 5,000 g/ha.
The doses herein indicated are given as illustrative Examples of method according to the invention. A person skilled in the art will know how to adapt the application doses, notably according to the nature of the plant or crop to be treated.
Under specific conditions, for example according to the nature of the phytopathogenic fungus to be treated or controlled, a lower dose can offer adequate protection. Certain climatic conditions, resistance or other factors like the nature of the phytopathogenic fungi or the degree of infestation, for example, of the plants with these fungi, can require higher doses of combined active ingredients. The optimum dose usually depends on several factors, for example on the type of phytopathogenic fungus to be treated, on the type or level of development of the infested plant, on the density of vegetation or alternatively on the method of application. Without it being limiting, the crop treated with the pesticide composition or combination according to the invention is, for example, grapevine, but this could be cereals, vegetables, lucerne, soybean, market garden crops, turf, wood, tree or horticultural plants.
The method of treatment according to the invention can also be useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots. The method of treatment according to the invention can also be useful to treat the over-ground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruit of the concerned plant. Among the plants that can be protected by the method according to the invention, mention can be made of cotton; flax; vine; fruit or vegetable crops such as Rosaceae sp. (for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for instance banana trees and plantins), Rubiaceae sp., Theaceae sp., Sterculiceae sp., Rutaceae sp. (for instance lemons oranges and grapefruit); Solanaceae sp. (for instance tomatoes), ϋliaceae sp., Asteraceae sp. (for instance lettuces), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp., Papilionaceae sp. (for instance peas), Rosaceae sp. (for instance strawberries); major crops such as Graminae sp. (for instance maize, lawn or cereals such as wheat, rice, barley and triticale), Asteraceae sp. (for instance sunflower), Cruciferae sp. (for instance colza), Fabacae sp. (for instance peanuts), Papilionaceae sp. (for instance soybean), Solanaceae sp. (for instance potatoes), Chenopodiaceae sp. (for instance beetroots); horticultural and forest crops; as well as genetically modified homologues of these crops.
The composition according to the invention can also be used against fungal diseases liable to grow on or inside timber. The term "timber" means all types of species of wood and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood and plywood. The method for treating timber according to the invention mainly consists in contacting one or more compounds according to the invention or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means.
Among the diseases of plants or crops that can be controlled by the method according to the invention, mention can be made of :
Powdery mildew diseases such as :
Blumeria diseases, caused for example by Blumeria graminis ;
Podosphaera diseases, caused for example by Podosphaera leucotricha ;
Sphaerotheca diseases, caused for example by Sphaerotheca fuliginea ;
Uncinula diseases, caused for example by Uncinula necator ;
Rust diseases such as :
Gymnosporangium diseases, caused for example by Gymnosporangium sabinae ;
Hemileia diseases, caused for example by Hemileia vastatrix ;
Phakopsora diseases, caused for example by Phakopsora pachyrhizior Phakopsora meibomiae ;
Puccinia diseases, caused for example by Puccinia recondita ;
Uromyces diseases, caused for example by Uromyces appendiculatus ;
Oomycete diseases such as :
Bremia diseases, caused for example by Bremia lactucae ;
Peronospora diseases, caused for example by Peronospora pisi or P. brassicae ;
Phytophthora diseases, caused for example by Phytophthora infestans ;
Plasmopara diseases, caused for example by Plasmopara viticola ;
Pseudoperonospora diseases, caused for example by Pseudoperonospora humuli or
Pseudoperonospora cubensis ;
Pythium diseases, caused for example by Pythium ultimum ; Leafspot, leaf blotch and leaf blight diseases such as :
Alternaria diseases, caused for example by Alternaria solani ;
Cercospora diseases, caused for example by Cercospora beticola ;
Cladiosporum diseases, caused for example by Cladiosporium cucumerinum ;
Cochliobolus diseases, caused for example by Cochliobolus sativus ;
Colletotrichum diseases, caused for example by Colletotrichum lindemuthanium ;
Cycloconium diseases, caused for example by Cycloconium oleaginum ;
Diaporthe diseases, caused for example by Diaporthe citri ;
Elsinoe diseases, caused for example by Elsinoe fawcettii ;
Gloeosporium diseases, caused for example by Gloeospohum laeticolor ;
Glomerella diseases, caused for example by Glomerella cingulata ;
Guignardia diseases, caused for example by Guignardia bidwelli ;
Leptosphaeria diseases, caused for example by Leptosphaeha maculans ; Leptosphaeha nodorum ;
Magnaporthe diseases, caused for example by Magnaporthe grisea ;
Mycosphaerella diseases, caused for example by Mycosphaerella graminicola ; Mycosphaerella arachidicola ; Mycosphaerella fijiensis ;
Phaeosphaeria diseases, caused for example by Phaeosphaeria nodorum ;
Pyrenophora diseases, caused for example by Pyrenophora teres ;
Ramularia diseases, caused for example by Ramularia collo-cygni ;
Rhynchosporium diseases, caused for example by Rhynchosporium secalis ;
Septoria diseases, caused for example by Septoria apii or Septoria lycopercisi ;
Typhula diseases, caused for example by Typhula incarnata ;
Venturia diseases, caused for example by Venturia inaequalis ;
Root and stem diseases such as :
Corticium diseases, caused for example by Corticium graminearum ;
Fusarium diseases, caused for example by Fusarium oxysporum ;
Gaeumannomyces diseases, caused for example by Gaeumannomyces graminis ;
Rhizoctonia diseases, caused for example by Rhizoctonia solani ;
Tapesia diseases, caused for example by Tapesia acuformis ;
Thielaviopsis diseases, caused for example by Thielaviopsis basicola ;
Ear and panicle diseases such as :
Alternaria diseases, caused for example by Alternaria spp. ;
Aspergillus diseases, caused for example by Aspergillus flavus ;
Cladosporium diseases, caused for example by Cladosporium spp. ;
Claviceps diseases, caused for example by Claviceps purpurea ;
Fusarium diseases, caused for example by Fusarium culmorum ;
Gibberella diseases, caused for example by Gibberella zeae ;
Monographella diseases, caused for example by Monographella nivalis ; Smut and bunt diseases such as :
Sphacelotheca diseases, caused for example by Sphacelotheca reiliana ;
Tilletia diseases, caused for example by Tilletia caries ;
Urocystis diseases, caused for example by Urocystis occulta ;
Ustilago diseases, caused for example by Ustilago nuda ;
Fruit rot and mould diseases such as :
Aspergillus diseases, caused for example by Aspergillus flavus ;
Botrytis diseases, caused for example by Botrytis cinerea ;
Penicillium diseases, caused for example by Penicillium expansum ;
Sclerotinia diseases, caused for example by Sclerotinia sclerotiorum ;
Verticilium diseases, caused for example by Verticilium alboatrum ;
Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases :
Alternaria diseases, caused for example by Alternaria brassicicola
Aphanomyces diseases, caused for example by Aphanomyces euteiches Ascochyta diseases, caused for example by Ascochyta lentis
Aspergillus diseases, caused for example by Aspergillus flavus
Cladosporium diseases, caused for example by Cladosporium herbarum
Cochliobolus diseases, caused for example by Cochliobolus sativus
(Conidiaform: Drechslera, Bipolaris Syn: Helminthosporium);
Colletotrichum diseases, caused for example by Colletotrichum coccodes;
Fusarium diseases, caused for example by Fusarium culmorum;
Gibberella diseases, caused for example by Gibberella zeae;
Macrophomina diseases, caused for example by Macrophomina phaseolina
Monographella diseases, caused for example by Monographella nivalis; Penicillium diseases, caused for example by Penicillium expansum
Phoma diseases, caused for example by Phoma lingam
Phomopsis diseases, caused for example by Phomopsis sojae;
Phytophthora diseases, caused for example by Phytophthora cactorum;
Pyrenophora diseases, caused for example by Pyrenophora graminea Pyricularia diseases, caused for example by Pyricularia oryzae;
Pythium diseases, caused for example by Pythium ultimum;
Rhizoctonia diseases, caused for example by Rhizoctonia solani;
Rhizopus diseases, caused for example by Rhizopus oryzae
Sclerotium diseases, caused for example by Sclerotium rolfsii;
Septoria diseases, caused for example by Septoria nodorum;
Typhula diseases, caused for example by Typhula incarnata;
Verticillium diseases, caused for example by Verticillium dahliae ;
Canker, broom and dieback diseases such as : Nectria diseases, caused for example by Nectria galligena ;
Blight diseases such as :
Monilinia diseases, caused for example by Monilinia laxa ;
Leaf blister or leaf curl diseases such as :
Taphrina diseases, caused for example by Taphrina deformans ;
Decline diseases of wooden plants such as :
Esca diseases, caused for example by Phaemoniella clamydospora ;
Eutypa dyeback, caused for example by Eutypa lata ;
Dutch elm disease, caused for example by Ceratocystsc ulmi ;
Diseases of flowers and Seeds such as :
Botrytis diseases, caused for example by Botrytis cinerea ;
Diseases of tubers such as :
Rhizoctonia diseases, caused for example by Rhizoctonia solani
Helminthosporium diseases, caused for example by Helminthosporium solani.
The method of treatment according to the invention can be used in the treatment of genetically modified organisms (GMOs), e.g. plants or seeds. Genetically modified plants (or transgenic plants) are plants in which a heterologous gene has been stably integrated into the genome. The expression "heterologous gene" essentially means a gene which is provided or assembled outside the plant and when introduced in the nuclear, chloroplastic or mitochondrial genome gives the transformed plant new or improved agronomic or other properties by expressing a protein or polypeptide of interest or by downregulating or silencing other gene(s) which are present in the plant (using for example, antisense technology, co suppression technology or RNA interference - RNAi - technology). A heterologous gene that is located in the genome is also called a transgene. A transgene that is defined by its particular location in the plant genome is called a transformation or transgenic event.
Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also result in superadditive
("synergistic") effects. Thus, for example, reduced application rates and/or a widening of the activity spectrum and/or an increase in the activity of the active compounds and compositions which can be used according to the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, bigger fruits, larger plant height, greener leaf color, earlier flowering, higher quality and/or a higher nutritional value of the harvested products, higher sugar concentration within the fruits, better storage stability and/or processability of the harvested products are possible, which exceed the effects which were actually to be expected. At certain application rates, the active compound combinations according to the invention may also have a strengthening effect in plants. Accordingly, they are also suitable for mobilizing the defense system of the plant against attack by unwanted phytopathogenic fungi and/ or microorganisms and/or viruses. This may, if appropriate, be one of the reasons of the enhanced activity of the combinations according to the invention, for example against fungi. Plant-strengthening (resistance-inducing) substances are to be understood as meaning, in the present context, those substances or combinations of substances which are capable of stimulating the defense system of plants in such a way that, when subsequently inoculated with unwanted phytopathogenic fungi and/ or microorganisms and/or viruses, the treated plants display a substantial degree of resistance to these unwanted phytopathogenic fungi and/ or microorganisms and/or viruses. In the present case, unwanted phytopathogenic fungi and/ or microorganisms and/or viruses are to be understood as meaning phytopathogenic fungi, bacteria and viruses. Thus, the substances according to the invention can be employed for protecting plants against attack by the abovementioned pathogens within a certain period of time after the treatment. The period of time within which protection is effected generally extends from 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds. Plants and plant cultivars which are preferably to be treated according to the invention include all plants which have genetic material which impart particularly advantageous, useful traits to these plants (whether obtained by breeding and/or biotechnological means).
Plants and plant cultivars which are also preferably to be treated according to the invention are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
Plants and plant cultivars which may also be treated according to the invention are those plants which are resistant to one or more abiotic stresses. Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozon exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
Plants and plant cultivars which may also be treated according to the invention, are those plants characterized by enhanced yield characteristics. Increased yield in said plants can be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield can furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
Plants that may be treated according to the invention are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stress factors. Such plants are typically made by crossing an inbred male-sterile parent line (the female parent) with another inbred male-fertile parent line (the male parent). Hybrid seed is typically harvested from the male sterile plants and sold to growers. Male sterile plants can sometimes (e.g. in corn) be produced by detasseling, i.e. the mechanical removal of the male reproductive organs (or males flowers) but, more typically, male sterility is the result of genetic determinants in the plant genome. In that case, and especially when seed is the desired product to be harvested from the hybrid plants it is typically useful to ensure that male fertility in the hybrid plants is fully restored. This can be accomplished by ensuring that the male parents have appropriate fertility restorer genes which are capable of restoring the male fertility in hybrid plants that contain the genetic determinants responsible for male-sterility. Genetic determinants for male sterility may be located in the cytoplasm. Examples of cytoplasmic male sterility (CMS) were for instance described in Brassica species (WO 1992/005251 , WO 1995/009910, WO 1998/27806, WO 2005/002324, WO 2006/021972 and US 6,229,072). However, genetic determinants for male sterility can also be located in the nuclear genome. Male sterile plants can also be obtained by plant biotechnology methods such as genetic engineering. A particularly useful means of obtaining male-sterile plants is described in WO 1989/10396 in which, for example, a ribonuclease such as barnase is selectively expressed in the tapetum cells in the stamens. Fertility can then be restored by expression in the tapetum cells of a ribonuclease inhibitor such as barstar (e.g. WO 1991/002069).
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may be treated according to the invention are herbicide-tolerant plants, i.e. plants made tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation, or by selection of plants containing a mutation imparting such herbicide tolerance.
Herbicide-tolerant plants are for example glyphosate-tolerant plants, i.e. plants made tolerant to the herbicide glyphosate or salts thereof. Plants can be made tolerant to glyphosate through different means. For example, glyphosate-tolerant plants can be obtained by transforming the plant with a gene encoding the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). Examples of such EPSPS genes are the AroA gene (mutant CT7) of the bacterium Salmonella typhimurium (Comai et al., Science (1983), 221 , 370-371 ), the CP4 gene of the bacterium Agrobacterium sp. (Barry et al., Curr. Topics Plant Physiol. (1992), 7, 139-145), the genes encoding a Petunia EPSPS (Shah et al., Science (1986), 233, 478-481 ), a Tomato EPSPS (Gasser et al., J. Biol. Chem. (1988),263, 4280-4289), or an Eleusine EPSPS (WO 2001/66704). It can also be a mutated EPSPS as described in for example EP-A 0837944, WO
2000/066746, WO 2000/066747 or WO 2002/026995. Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate oxido-reductase enzyme as described in US 5,776,760 and US 5,463,175. Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate acetyl transferase enzyme as described in for example WO 2002/036782, WO 2003/092360, WO 2005/012515 and WO 2007/024782. Glyphosate-tolerant plants can also be obtained by selecting plants containing naturally-occurring mutations of the above-mentioned genes, as described in for example WO 2001/024615 or WO 2003/013226.
Other herbicide resistant plants are for example plants that are made tolerant to herbicides inhibiting the enzyme glutamine synthase, such as bialaphos, phosphinothricin or glufosinate. Such plants can be obtained by expressing an enzyme detoxifying the herbicide or a mutant glutamine synthase enzyme that is resistant to inhibition. One such efficient detoxifying enzyme is an enzyme encoding a phosphinothricin acetyltransferase (such as the bar or pat protein from Streptomyces species). Plants expressing an exogenous phosphinothricin acetyltransferase are for example described in US 5,561 ,236; US 5,648,477;
US 5,646,024; US 5,273,894; US 5,637,489; US 5,276,268; US 5,739,082; US 5,908,810 and US
7,112,665.
Further herbicide-tolerant plants are also plants that are made tolerant to the herbicides inhibiting the enzyme hydroxyphenylpyruvatedioxygenase (HPPD). Hydroxyphenylpyruvatedioxygenases are enzymes that catalyze the reaction in which para-hydroxyphenylpyruvate (HPP) is transformed into homogentisate. Plants tolerant to HPPD-inhibitors can be transformed with a gene encoding a naturally-occurring resistant HPPD enzyme, or a gene encoding a mutated HPPD enzyme as described in WO 1996/038567, WO 1999/024585 and WO 1999/024586. Tolerance to HPPD-inhibitors can also be obtained by transforming plants with genes encoding certain enzymes enabling the formation of homogentisate despite the inhibition of the native HPPD enzyme by the HPPD-inhibitor. Such plants and genes are described in WO 1999/034008 and WO 2002/36787. Tolerance of plants to HPPD inhibitors can also be improved by transforming plants with a gene encoding an enzyme prephenate dehydrogenase in addition to a gene encoding an HPPD-tolerant enzyme, as described in WO 2004/024928.
Still further herbicide resistant plants are plants that are made tolerant to acetolactate synthase (ALS) inhibitors. Known ALS-inhibitors include, for example, sulfonylurea, imidazolinone, triazolopyrimidines, pyrimidinyloxy(thio)benzoates, and/or sulfonylaminocarbonyltriazolinone herbicides. Different mutations in the ALS enzyme (also known as acetohydroxyacid synthase, AHAS) are known to confer tolerance to different herbicides and groups of herbicides, as described for example in Tranel and Wright, Weed Science (2002), 50, 700-712, but also, in US 5,605,01 1 , US 5,378,824, US 5,141 ,870, and US 5,013,659. The production of sulfonylurea-tolerant plants and imidazolinone-tolerant plants is described in US 5,605,01 1 ; US 5,013,659; US 5,141 ,870; US 5,767,361 ; US 5,731 ,180; US 5,304,732; US 4,761 ,373; US 5,331 ,107; US 5,928,937; and US 5,378,824; and international publication WO 1996/033270. Other imidazolinone-tolerant plants are also described in for example WO 2004/040012, WO 2004/106529, WO 2005/020673, WO 2005/093093, WO 2006/007373, WO 2006/015376, WO 2006/024351 , and WO 2006/060634. Further sulfonylurea- and imidazolinone-tolerant plants are also described in for example WO 2007/024782. Other plants tolerant to imidazolinone and/or sulfonylurea can be obtained by induced mutagenesis, selection in cell cultures in the presence of the herbicide or mutation breeding as described for example for soybeans in US 5,084,082, for rice in WO 1997/41218, for sugar beet in US 5,773,702 and WO 1999/057965 , for lettuce in US 5,198,599, or for sunflower in WO 2001/065922.
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are insect-resistant transgenic plants, i.e. plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such insect resistance.
An "insect-resistant transgenic plant", as used herein, includes any plant containing at least one transgene comprising a coding sequence encoding:
1 ) an insecticidal crystal protein from Bacillus thuringiensis or an insecticidal portion thereof, such as the insecticidal crystal proteins listed by Crickmore et al., Microbiology and Molecular Biology Reviews (1998), 62, 807-813, updated by Crickmore et al. (2005) at the Bacillus thuringiensis toxin nomenclature, online at:
http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/), or insecticidal portions thereof, e.g., proteins of the Cry protein classes CrylAb, CryiAc, Cry1 F, Cry2Ab, Cry3Aa, or Cry3Bb or insecticidal portions thereof; or
2) a crystal protein from Bacillus thuringiensis or a portion thereof which is insecticidal in the presence of a second other crystal protein from Bacillus thuringiensis or a portion thereof, such as the binary toxin made up of the Cry34 and Cry35 crystal proteins (Moellenbeck et al., Nat.
Biotechnol. (2001 ), 19, 668-72; Schnepf et al., Applied Environm. Microbiol. (2006), 71 , 1765- 1774); or
3) a hybrid insecticidal protein comprising parts of different insecticidal crystal proteins from Bacillus thuringiensis, such as a hybrid of the proteins of 1 ) above or a hybrid of the proteins of 2) above, e.g., the Cry1A.1O5 protein produced by corn event MON98034 (WO 2007/027777); or
4) a protein of any one of 1 ) to 3) above wherein some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain a higher insecticidal activity to a target insect species, and/or to expand the range of target insect species affected, and/or because of changes introduced into the encoding DNA during cloning or transformation, such as the Cry3Bb1 protein in corn events MON863 or MON88017, or the Cry3A protein in corn event MIR604;
5) an insecticidal secreted protein from Bacillus thuringiensis or Bacillus cereus, or an insecticidal portion thereof, such as the vegetative insecticidal (VIP) proteins listed at:
http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/vip.html, e.g., proteins from the VIP3Aa protein class; or
6) a secreted protein from Bacillus thuringiensis or Bacillus cereus which is insecticidal in the presence of a second secreted protein from Bacillus thuringiensis or β. cereus, such as the binary toxin made up of the VIPIA and VIP2A proteins (WO 1994/21795); or 7) a hybrid insecticidal protein comprising parts from different secreted proteins from Bacillus thuringiensis or Bacillus cereus, such as a hybrid of the proteins in 1 ) above or a hybrid of the proteins in 2) above; or
8) a protein of any one of 1 ) to 3) above wherein some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain a higher insecticidal activity to a target insect species, and/or to expand the range of target insect species affected, and/or because of changes introduced into the encoding DNA during cloning or transformation (while still encoding an insecticidal protein), such as the VIP3Aa protein in cotton event COT102.
Of course, an insect-resistant transgenic plant, as used herein, also includes any plant comprising a combination of genes encoding the proteins of any one of the above classes 1 to 8. In one embodiment, an insect-resistant plant contains more than one transgene encoding a protein of any one of the above classes 1 to 8, to expand the range of target insect species affected when using different proteins directed at different target insect species, or to delay insect resistance development to the plants by using different proteins insecticidal to the same target insect species but having a different mode of action, such as binding to different receptor binding sites in the insect.
Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are tolerant to abiotic stresses. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such stress resistance. Particularly useful stress tolerance plants include: a. plants which contain a transgene capable of reducing the expression and/or the activity of poly(ADP-ribose)polymerase (PARP) gene in the plant cells or plants as described in WO 2000/004173 or WO2006/045633 or PCT/EP07/004142. b. plants which contain a stress tolerance enhancing transgene capable of reducing the expression and/or the activity of the PARG encoding genes of the plants or plants cells, as described e.g. in WO 2004/090140. c. plants which contain a stress tolerance enhancing transgene coding for a plant- functional enzyme of the nicotinamide adenine dinucleotide salvage synthesis pathway including nicotinamidase, nicotinate phosphoribosyltransferase, nicotinic acid mononucleotide adenyl transferase, nicotinamide adenine dinucleotide synthetase or nicotine amide phosphoribosyltransferase as described e.g. in WO2006/032469 or WO 2006/133827 or PCT/EP07/002433. Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention show altered quantity, quality and/or storage-stability of the harvested product and/or altered properties of specific ingredients of the harvested product such as :
1 ) transgenic plants which synthesize a modified starch, which in its physical-chemical characteristics, in particular the amylose content or the amylose/amylopectin ratio, the degree of branching, the average chain length, the side chain distribution, the viscosity behaviour, the gelling strength, the starch grain size and/or the starch grain morphology, is changed in comparison with the synthesised starch in wild type plant cells or plants, so that this is better suited for special applications. Said transgenic plants synthesizing a modified starch are disclosed, for example, in EP 0571427, WO 1995/004826, EP 0719338, WO 1996/15248, WO 1996/19581 , WO 1996/27674, WO 1997/11188, WO 1997/26362, WO 1997/32985, WO
1997/42328, WO 1997/44472, WO 1997/45545, WO 1998/27212, WO 1998/40503, WO99/58688,
WO 1999/58690, WO 1999/58654, WO 2000/008184, WO 2000/008185, WO 2000/008175, WO 2000/28052, WO 2000/77229, WO 2001/12782, WO 2001/12826, WO 2002/101059, WO
2003/071860, WO 2004/056999, WO 2005/030942, WO 2005/030941 , WO 2005/095632, WO 2005/095617, WO 2005/095619, WO 2005/095618, WO 2005/123927, WO 2006/018319, WO 2006/103107, WO 2006/108702, WO 2007/009823, WO 2000/22140, WO 2006/063862, WO
2006/072603, WO 2002/034923, EP 06090134.5, EP 06090228.5, EP 06090227.7, EP
07090007.1 , EP 07090009.7, WO 2001/14569, WO 2002/79410, WO 2003/33540, WO
2004/078983, WO 2001/19975, WO 1995/26407, WO 1996/34968, WO 1998/20145, WO
1999/12950, WO 1999/66050, WO 1999/53072, US 6,734,341 , WO 2000/1 1192, WO
1998/22604, WO 1998/32326, WO 2001/98509, WO 2001/98509, WO 2005/002359, US
5,824,790, US 6,013,861 , WO 1994/004693, WO 1994/009144, WO 1994/11520, WO
1995/35026, WO 1997/20936.
2) transgenic plants which synthesize non starch carbohydrate polymers or which synthesize non starch carbohydrate polymers with altered properties in comparison to wild type plants without genetic modification. Examples are plants producing polyfructose, especially of the inulin and levan-type, as disclosed in EP 0663956, WO 1996/001904, WO 1996/021023, WO 1998/039460, and WO 1999/024593, plants producing alpha 1 ,4 glucans as disclosed in WO 1995/031553, US 2002/031826, US 6,284,479, US 5,712,107, WO 1997/047806, WO 1997/047807, WO
1997/047808 and WO 2000/014249, plants producing alpha-1 ,6 branched alpha-1 ,4-glucans, as disclosed in WO 2000/73422, plants producing alternan, as disclosed in WO 2000/047727, EP
06077301.7, US 5,908,975 and EP 0728213,
3) transgenic plants which produce hyaluronan, as for example disclosed in WO 2006/032538, WO 2007/039314, WO 2007/039315, WO 2007/039316, JP 2006/304779, and WO 2005/012529. Plants or plant cultivars (that can be obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants, such as cotton plants, with altered fiber characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered fiber characteristics and include: a) Plants, such as cotton plants, containing an altered form of cellulose synthase genes as described in WO 1998/000549
b) Plants, such as cotton plants, containing an altered form of rsw2 or rsw3 homologous nucleic acids as described in WO2004/053219
c) Plants, such as cotton plants, with increased expression of sucrose phosphate synthase as described in WO 2001/017333
d) Plants, such as cotton plants, with increased expression of sucrose synthase as described in WO02/45485
e) Plants, such as cotton plants, wherein the timing of the plasmodesmatal gating at the basis of the fiber cell is altered, e.g. through down regulation of fiberselective β 1 ,3-glucanase as described in WO2005/017157
f) Plants, such as cotton plants, having fibers with altered reactivity, e.g. through the expression of N-acteylglucosaminetransferase gene including nodC and chitinsynthase genes as described in WO2006/136351
Plants or plant cultivars (that can be obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants, such as oilseed rape or related Brassica plants, with altered oil profile characteristics. Such plants can be obtained by genetic transformation or by selection of plants contain a mutation imparting such altered oil characteristics and include:
a) Plants, such as oilseed rape plants, producing oil having a high oleic acid content as described e.g. in US 5,969,169, US 5,840,946 or US 6,323,392 or US 6,063,947 b) Plants such as oilseed rape plants, producing oil having a low linolenic acid content as described in US 6,270828, US 6,169,190 or US 5,965,755
c) Plant such as oilseed rape plants, producing oil having a low level of saturated fatty acids as described e.g. in US 5,434,283
Particularly useful transgenic plants which may be treated according to the invention are plants which comprise one or more genes which encode one or more toxins, such as the following which are sold under the trade names YIELD GARD® (for example maize, cotton, soya beans), KnockOut® (for example maize), BiteGard® (for example maize), Bt-Xtra® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton), Nucotn 33B®(cotton), NatureGard® (for example maize), Protecta® and NewLeaf® (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soya bean varieties which are sold under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned include the varieties sold under the name Clearfield® (for example maize).
Particularly useful transgenic plants which may be treated according to the invention are plants containing transformation events, or combination of transformation events, that are listed for example in the databases from various national or regional regulatory agencies (see for example
http://gmoinfo.jrc.it/gmp_browse.aspx and http://www.agbios.com/dbase.php).
The compounds according to the invention can also be used for the preparation of composition useful to curatively or preventively treat human or animal fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
Preparation Examples
Synthesis of butyl [4-({[1-(1-methyl-1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)-1 ,3-thiazol-2-yl]carbamate (ex.
21 )
To a solution of 144mg (0.49mmol) of 4-({[1-(1-methyl-1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)-1 ,3-thiazol-
2-amine (prepared as described in JP2005-41793) in 10ml of dioxane, were added 52mg (0.66mmol) of pyridine and 5.4mg (0.04mmol) of 4-dimethylaminopyridine, followed by 120mg (O.δδmmol) of butyl chhloroformate. The resulting reaction mixture was stirred at room temperature overnight. To the reaction mixture was added 30ml of an aqueous solution of sodium hydrogen carbonate (10g/L), and the resulting mixture was extracted with 50ml of ethyl acetate. The organic phase was dried and solvent evaporated to give the crude product which was purified on silica to give 95mg of the expected butyl [4-({[1-(1-methyl- 1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)-1 ,3-thiazol-2-yl]carbamate.
Synthesis of 5-(2-{[2-(hept-1-yn-1-yl)-1 ,3-thiazol-4-yl]methoxy}-1-naphthyl)-1-methyl-1 H-tetrazole (ex. 7)
Step 1 : synthesis of 5-{2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1-naphthyl}-1-methyl-1 H-tetrazole
A mixture of 1.13g (4.4mmol) of 1-(1-methyl-1 H-tetrazol-5-yl)-2-naphthol (prepared as described in JP2005-41793) and 1 ,00gr (4.4mmol) of 2-bromo-4-(bromomethyl)-1 ,3-thiazole in 10 ml of acetonitrile was stirred at room temperature overnight. The reaction mixture was diluted with 30ml of water, and then extracted with ethyl acetate. The organic phase was dried and solvent evaporated to give the expected product synthesis of 5-{2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1-naphthyl}-1-methyl-1 H-tetrazole.
Step 2 : To 5ml of tetrahydrofuran were added3.5mg (0.01 mmol) of copper iodide, 143mg (1.49mnnol) of heptyne, 150mg (0.37mmol) of 5-{2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1-naphthyl}-1-methyl-1 H-tetrazole (as obtained in step 1 ), 193mg (1.49mnnol) of N,N-diisopropylethylamine and 21.6mg (O.OI mmol) of tetrakis(triphenylphosphine)palladium(0) in a sealed tube under argon atmosphere. The reaction mixture was left to stand at room temperature overnight. Filtration on chemelut, and solvent evaporation of the filtatre were performed before the product was purified with HPLC.
Synthesis of propyl [6-({[1-(1-methyl-1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)pyridin-2-yl]carbamate (ex. 27)
To a solution of 196mg (0.59mmol) of 6-({[1-(1-methyl-1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)pyridin-2- amine (prepared as described in JP2005-41793) in 10ml of dioxane, were added 70mg (0.88mmol) of pyridine and 7.2mg (0.05mmol) of 4-dimethylaminopyridine, followed by 145mg (0.1.18mol) of propyl chhloroformate. The resulting reaction mixture was stirred at room temperature overnight. To the reaction mixture was added 30ml of an aqueous solution of sodium hydrogen carbonate (10g/L), and the resulting mixture was extracted with 50ml of ethyl acetate. The organic phase was dried and solvent evaporated to give the crude product which was purified on silica to give 107mg of the expected propyl [6-({[1-(1-methyl- 1 H-tetrazol-5-yl)-2-naphthyl]oxy}methyl)pyridin-2-yl]carbamate.
In analogy to the examples above and according to the general description of the processes of preparing the compounds according to the invention the compounds in the following Table 1 may be obtained.
Figure imgf000045_0001
In table 1 A in (I) can have for example the values A1 , A2 and Z:
Figure imgf000045_0002
Table 1
Figure imgf000045_0003
Figure imgf000046_0001
Figure imgf000047_0001
Measurement of logP values was performed according EEC directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on reversed phase columns with the following methods:
[a] measurement of LC-MS was done at pH 2,7 with 0,1 % formic acid in water and with acetonitrile (contains 0,1 % formic acid) as eluent with a linear gradient from 10 % acetonitrile to 95 % acetonitrile.
Calibration was done with not branched alkan2-ones (with 3 to 16 carbon atoms) with known logP-values (measurement of logP values using retention times with linear interpolation between successive alkanones). Lambdamax values were determined using UV-spectra from 200 nm to 400 nm and the peak values of the chromatographic signals.
In table 1 , M+H (or M H) means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass unit) respectively, as observed in mass spectroscopy and M (APCI+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionization in mass spectroscopy.
Biological Examples
Phytophthora test (tomato) / preventive
Solvent: 49 parts by weight of N, N - Dimethylformamide
Emulsifier: 1 part by weight of Alkylarylpolyglycolether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
To test for preventive activity, young plants are sprayed with the preparation of active compound at the stated rate of application. One day after this treatment, the plants are inoculated with an aqueous spore suspension of Phytophthora infestans. The plants remain for one day in an incubation cabinet at approximately 22°C and a relative atmospheric humidity of 100%. Then the plants are placed in an incubation cabinet at approximately 200C and a relative atmospheric humidity of 96%.
The test is evaluated 7 days after the inoculation. 0% means an efficacy which corresponds to that of the untreated control, while an efficacy of 100% means that no disease is observed. In this test the following compounds according to the invention showed efficacy of 70% or even higher at a concentration of 500ppm of active ingredient and the concrete values in percent are shown in parentheses as follows:
Example 4 (80 %), 13 (95 %), 17 (95 %), 18 (80 %), 20 (80 %), 21 (95 %), 22 (70 %), 25 (70 %) and 28 (90 %).

Claims

1. A compound of formula (I)
Figure imgf000049_0001
(I) wherein
• Q1 represents N or CY3 ;
• Q2 represents N or CY4
• Y1, Y2, Y3 and Y4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, hydroxycarbonyl, Ci-C8-alkoxycarbonyl, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde 0-(C1-C8- alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non- substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted
Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbonyl, substituted or non-substituted N-(C1 -C8-alkoxy)-C-ι -C8- alkanimidoyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-halogenoalkaninnidoyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamoyl, substituted or non- substituted di-Ci-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbannoyl, substituted or non-substituted N-C1-C8- alkyl-Ci-C8-alkoxycarbamoyl, substituted or non-substituted d-Cs-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-alkylcarbonyloxy, substituted or non-substituted C1-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to
5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbamoylamino, substituted or non- substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-C-i-Cs-alkylcarbamoylamino, substituted or non-substituted CIi-C1-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N- C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(C1-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N- C1-C8-alkyl-(di-C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl-(di- C-ι-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylaminocarbonyloxy, substituted or non-substituted di-d-Cs-alkylaminocarbonyloxy, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted CIi-C1-C8- alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyl, substituted or non-substituted d-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C1 -C8-alkyl-d -C8- alkoxycarbamothioyl, substituted or non-substituted C-i-Cs-alkylthioylamino, substituted or non- substituted d-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non- substituted (d-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non- substituted (di-d-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted d-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non-substituted C1-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminosulfamoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted (d-C6-alkoxyinnino)-d-C6-alkyl, substituted or non-substituted (C1-C6- alkenyloxyimino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkynyloxyinnino)-d-C6-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non-substituted tri(d-C8-alkyl)- silyloxy, substituted or non-substituted d-C8-alkylsulfenylannino, substituted or non-substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylsulphonylamino, substituted or non-substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkoxysulphonylannino, substituted or non-substituted Ci-C8-halogenoxysulphonylannino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8-alkyl)-silyl, substituted or non-substituted (Ci-C6- alkylideneamino)oxy, substituted or non-substituted (d-C6-alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]-[d-C8]-alkyl, substituted or non-substituted [{d-C8-alkyl(d-C8-alkylcarbonyl)amino}]-[d-C8]-alkyl, substituted or non-substituted [{d-C8-alkyl(arylcarbonyl)amino}]-[d-C8]-alkyl, substituted or non-substituted
[(d-C8-alkylcarbonyl)amino]-[d-C8]-alkyl t substituted or non-substituted heterocyclyl, substituted or non-substituted heterocyclyloxy, or
• when Y1 and Y2 together with the aromatic cycle to which they are attached do form a naphtyl, quinoleine or isoquinoleine, Y3 and Y4 are as defined above;
• n represents 1 , 2, 3 or 4 ;
• R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphanyl, substituted or non-substituted Ci-C8-halogeno alkylsulphanyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenylsulphanyl, substituted or non- substituted C2-C8-halogeno alkenylsulphanyl having 1 to 5 halogen atoms, substituted or non- substituted C3-C8-alkynylsulphenyl, substituted or non-substituted C3-C8-halogeno alkynylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogeno alkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenylsulphenyl, substituted or non-substituted C2-C8- halogeno alkenylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynylsulphenyl, substituted or non-substituted C3-C8-halogeno alkynylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted Ci-C8-halogeno alkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8- alkenylsulphinyl, substituted or non-substituted C2-C8-halogeno alkenylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynylsulphinyl, substituted or non- substituted C3-C8-halogenoalkynylsulphinyl having 1 to 5 halogen atoms, • T represents a hydrogen or a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T1 to T32 :
Figure imgf000052_0001
Figure imgf000053_0001
wherein
• X1 to X4 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(CrC8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non- substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3- C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non- substituted di-d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non- substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1- C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2- C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(Ci-C8- alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci -C8-alkoxy)-Ci -C8- halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non- substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted d-Cs-halogenoalkylcarbamoylannino having 1 to 5 halogen atoms, substituted or non-substituted di-d-Cs-alkylcarbamoylannino, substituted or non-substituted di-d-Cs-halogenoalkylcarbamoylannino having 1 to 5 halogen atoms , substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(di-Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylaminocarbonyloxy, substituted or non-substituted CIi-C1-C8- alkylaminocarbonyloxy, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyl, substituted or non-substituted d-C8-alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyll, substituted or non-substituted C1-C8- alkylthioylamino, substituted or non-substituted d-C8-halogenoalkylthioylannino having 1 to 5 halogen atoms, substituted or non-substituted (d-C8-alkyl-carbamothioyl)-oxy, substituted or non- substituted substituted or non-substituted (di-d-C8-alkyl-carbamothioyl)-oxy, substituted or non- substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted d-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkylsulphonyl, substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylaminosulfannoyl, substituted or non-substituted di-d-Cs-alkylaminosulfannoyl, substituted or non-substituted (C1-C6- alkoxyimino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkenyloxyinnino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkynyloxyinnino)-d-C6-alkyl, substituted or non-substituted (benzyloxyimino)-d-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non- substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non- substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non- substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl- [d-C8]-alkyl, substituted or non-substituted tri(d-C8-alkyl)-silyloxy, substituted or non-substituted C-ι-C8-alkylsulfenylamino, substituted or non-substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylsulphonylamino, substituted or non-substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkoxysulphonylannino, substituted or non-substituted C1-C8- halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8- alkyl)-silyl, substituted or non-substituted (d-C6-alkylideneannino)oxy, substituted or non- substituted (d-C6-alkenylideneannino)oxy, substituted or non-substituted (C1-C6- alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy ; • W1 independently represents a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C"rC8-alkyl)oxinne, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non- substituted tri(C-ι-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted C1-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted d- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci-C8- alkoxy)-C-ι-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-C-ι-C8-alkylcarbamoyl, substituted or non- substituted N-C-ι-C8-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non-substituted N-C-ι-C8-alkyl-C-ι-C8-alkoxycarbamoyl, substituted or non- substituted C-rCs-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamothioyll, substituted or non-substituted d-Cs-alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyl, substituted or non-substituted Ci-C8- alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8-alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl ;
A is selected in the list consisting of A1 to A 116
Figure imgf000055_0001
Figure imgf000056_0001
Figure imgf000057_0001
Figure imgf000058_0001
Figure imgf000059_0001
wherein • Z1, Z2, Z3, Z4 Z5, Z6, Z7, Z8 and Z9 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)- amino group, a substituted or non-substituted (hydroxyimino)-C-ι-C6-alkyl group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-
C3-C8-cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8- alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8- alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted (Ci-C8-alkoxycarbonyl)amino, substituted or non- substituted (C3-C8-cycloalkoxycarbonyl)amino, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted (C2-C8- alkenyloxycarbonyl)amino, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non- substituted N-(Ci-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci -C8-alkoxy)- Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non- substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-Ci-C8-alkylcarbamoylamino, substituted or non-substituted di-Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-halogenoalkylcarbamoyl)annino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-alkylcarbannoyl)annino, substituted or non-substituted N- Ci-C8-alkyl-(di-Ci-C8-halogenoalkylcarbamoyl)annino having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8- alkylaminocarbonyloxy, substituted or non-substituted Ci-Cs-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyl, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C-rCs-alkyl-C-rCs-alkoxycarbamothioyl, substituted or non-substituted C1-C8- alkylthioylamino, substituted or non-substituted (C-i-Cs-alkoxythiocarbony^amino, substituted or non-substituted C-rCs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non- substituted (d-Cs-alkyl-carbamothioy^-oxy, substituted or non-substituted substituted or non- substituted (di-C-i-Cs-alkyl-carbamothioy^-oxy, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-i-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphinyl, substituted or non-substituted C1-C8- halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkyl- sulphonyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted (C-i-Ce-alkoxyimino^C-i-Cβ-alkyl, substituted or non-substituted (C-i-Ce-alkenyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (C-i-Ce-alkynyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted (arylcarbonyl)amino, substituted or non-substituted (heterocyclylcarbony^amino, substituted or non-substituted (aryloxcarbonyl)amino, substituted or non-substituted (heterocyclyloxycarbony^amino, substituted or non-substituted tri(C-ι-C8-alkyl)- silyloxy, substituted or non-substituted C-ι-C8-alkylsulfenylamino, substituted or non-substituted C-i-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted C-i-C8-alkylsulphonylamino, substituted or non-substituted C-i-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxysulphonylamino, substituted or non-substituted C-ι-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl, substituted or non-substituted (C1-C6- alkylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkenylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy; provided that when T represents T28, T29, T31 or T32 and when Y1 and Y2 together with the aromatic cycle to which they are attached form a naphtyl and when A represents A2 , A6, A11, A12, A14, A15, A18, A25, A26, A29 or A31 then Z1 represents a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted C-i-Cs-alkoxyannino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-annino group, substituted or non-substituted (C"rC8-alkylannino)-annino group, substituted or non- substituted N-C-ι-C8-alkyl-(C-ι-C8-alkylannino)-annino group, a substituted or non-substituted
(hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted
C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted d- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylsulphenyl, substituted or non-substituted C-i-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(C1 -C8-alkoxy)-d -C8- alkanimidoyl, substituted or non-substituted N-(d-C8-alkoxy)-d-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non- substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8- alkylcarbamothioyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamothioyl, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamothioyl, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non- substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted Ci-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C8- alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-Ci-C8- alkyl-carbamothioyl)-oxy, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non- substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8- alkylaminosulfamoyl, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (C1-C6- alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted tri(d-C8-alkyl)-silyloxy, substituted or non- substituted C-rCs-alkylsulfenylamino, substituted or non-substituted C1-C8- halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphonylamino, substituted or non-substituted C-rCs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxysulphonylamino, substituted or non-substituted C-ι-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl, substituted or non-substituted (C-ι-C6-alkylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkenylideneamino)oxy, substituted or non-substituted (C1- C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy;;
• K1 and K2 independently represent a hydrogen atom, a formyl group, a substituted or non- substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non- substituted tri(C"rC8-alkyl)silyl-C3-C8-cycloalkyl, substituted or non-substituted C1-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted C-ι-C8-alkylamino, substituted or non-substituted di- C-i-Cs-alkylamino, substituted or non-substituted C-ι-C8-alkoxy, substituted or non-substituted C1-
C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbonyl, substituted or non-substituted N-(C1-C8-alkoxy)-C1-C8-alkanimidoyl, substituted or non-substituted N-(C1-C8- alkoxy)-C-ι-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-C-i-Cs-alkylcarbamoyl, substituted or non- substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted C-i-Cs-alkoxycarbamoyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non- substituted C-i-Cs-alkoxycarbonyl, substituted or non-substituted C-i-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyll, substituted or non-substituted d-Cs-alkoxycarbannothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbannothioyl, substituted or non-substituted Ci-C8- alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminosulfamoyl, substituted or non-substituted di-Ci-Cs-alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl ;
• G1 and G2 are independently selected in the list consisting of oxygen, sulfur, NR3, N-OR4 and N-NR5R6 wherein R3 to R6 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8- alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having
1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl ; ell as salts, N-oxides, metallic complexes and metalloidic complexes thereof
2. Compound according to claim 1 , selected from the compounds of formula (Ia), (Ib) and (Ic)
Figure imgf000064_0001
(Ia) (Ib) (Ic) wherein
• A, T, n, R1 , R2, Y3 and Y4 are defined according to claim 1 ;
• Y5 to Y8 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted C3-C8-Cy cloa Iky I, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylsulphenyl, substituted or non-substituted d-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non- substituted C3-C8-alkynyloxy, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted d-Cs-alkoxycarbonyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl;
3. Compound according to claim 1 or 2, wherein Y1, Y2, Y3 and Y4 independently represent a hydrogen atom, a halogen atom, a cyano group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl.
4. Compound according to anyone of claims 1 to 4, wherein Y1, Y2, Y3 and Y4 independently represent a hydrogen atom or a fluorine atom.
5. Compound according to anyone of claims 1 to 4, wherein n represents 1.
6. Compound according to anyone of claims 1 to 5, wherein R1 and R2 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted Ci-C8-alkyl.
7. Compound according to anyone of claims 1 to 6, wherein T represents a substituted or non- substituted heterocyclyl group that is selected in the list consisting of T27 to T32.
8. Compound according to anyone of claims 1 to 7, wherein X1 to X4 independently represent a hydrogen atom, a halogen atom, a substituted or non-substituted carbaldehyde 0-(C1-C8- alkyl)oxime, substituted or non-substituted d-C8-alkyl, substituted or non-substituted C3-C8- cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2- C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8- alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms.
9. Compound according to anyone of claims 1 to 8, wherein W1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl.
10. Compound according to anyone of claims 1 to 9, wherein A is selected in the list consisting of A2, A6, A8, A11 to A18.
11. Compound according to anyone of claims 1 to 10, wherein Z1 represents an amino group, a halogen atom, a formylamino group, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non-substituted (C-ι-C8-alkoxycarbonyl)amino, substituted or non-substituted (C3-C8- cycloalkoxycarbonyl)amino, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (Cs-Cs-alkynyloxycarbony^amino, substituted or non- substituted d-Cs-alkylcarbonylamino, substituted or non-substituted (arylcarbonyl)amino, substituted or non-substituted (heterocyclylcarbony^amino, substituted or non-substituted (aryloxycarbonyl)amino, substituted or non-substituted (heterocyclyloxycarbony^amino.
12. Compound according to anyone of claims 1 to 1 1 , wherein Z2 to Z9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
13. Compound according to anyone of claims 1 to 12, wherein K1 and K2 are independently selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
14. Compound according to anyone of claims 1 to 13, wherein Y5 to Y8 independently represent a hydrogen atom, a halogen atom, substituted or non-substituted d-C8-alkyl.
15. A method for the preparation of compounds according to anyone of claims 1 to 14, according to the following reaction schemes:
Figure imgf000067_0001
(H) (ill) (I) wherein T, A, Q1, Q2, Y1, Y2, R1, R2 and n are as defined in claims 1 to 14 and LG represents a leaving group selected in the list consisting of a halogen atom or other customary nucleofugal groups.
16. A fungicide composition comprising, as an active ingredient, an effective amount of a compound of formula (I) according to claims 1 to 14 and an agriculturally acceptable support, carrier or filler.
17. A method for controlling phytopathogenic fungi of plants, crops or seeds, characterized in that an agronomically effective and substantially non-phytotoxic quantity of a compound according to claims 1 to 14 or a fungicide composition according to claim 16 is applied to the soil where plants grow or are capable of growing, to the leaves and/or the fruit of plants or to the seeds of plants.
PCT/EP2010/061082 2009-08-03 2010-07-30 Fungicide heterocycles derivatives WO2011015524A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09356051.4 2009-08-03
EP09356051 2009-08-03

Publications (2)

Publication Number Publication Date
WO2011015524A2 true WO2011015524A2 (en) 2011-02-10
WO2011015524A3 WO2011015524A3 (en) 2011-05-19

Family

ID=41202629

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/061082 WO2011015524A2 (en) 2009-08-03 2010-07-30 Fungicide heterocycles derivatives

Country Status (1)

Country Link
WO (1) WO2011015524A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071495A (en) * 2016-04-13 2018-12-21 瑞戴格作物保护公司 Agricultural chemicals
JP2020505347A (en) * 2017-01-13 2020-02-20 レダッグ クロップ プロテクション リミテッド Thiobenzimidazole as a fungicide
US11014908B2 (en) 2018-11-29 2021-05-25 Pfizer Inc. Chemical compounds

Citations (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
WO1989010396A1 (en) 1988-04-28 1989-11-02 Plant Genetic Systems N.V. Plants with modified stamen cells
WO1991002069A1 (en) 1989-08-10 1991-02-21 Plant Genetic Systems N.V. Plants with modified flowers
US5013659A (en) 1987-07-27 1991-05-07 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5084082A (en) 1988-09-22 1992-01-28 E. I. Du Pont De Nemours And Company Soybean plants with dominant selectable trait for herbicide resistance
WO1992005251A1 (en) 1990-09-21 1992-04-02 Institut National De La Recherche Agronomique Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
US5198599A (en) 1990-06-05 1993-03-30 Idaho Resarch Foundation, Inc. Sulfonylurea herbicide resistance in plants
EP0571427A1 (en) 1991-02-13 1993-12-01 Hoechst Schering AgrEvo GmbH Plasmids containing dna-sequences that cause changes in the carbohydrate concentration and the carbohydrate composition in plants, as well as plant cells and plants containing these plasmids
US5273894A (en) 1986-08-23 1993-12-28 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5276268A (en) 1986-08-23 1994-01-04 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
WO1994004693A2 (en) 1992-08-26 1994-03-03 Zeneca Limited Novel plants and processes for obtaining them
US5304732A (en) 1984-03-06 1994-04-19 Mgi Pharma, Inc. Herbicide resistance in plants
WO1994009144A1 (en) 1992-10-14 1994-04-28 Zeneca Limited Novel plants and processes for obtaining them
WO1994011520A2 (en) 1992-11-09 1994-05-26 Zeneca Limited Novel plants and processes for obtaining them
US5331107A (en) 1984-03-06 1994-07-19 Mgi Pharma, Inc. Herbicide resistance in plants
WO1994021795A1 (en) 1993-03-25 1994-09-29 Ciba-Geigy Ag Novel pesticidal proteins and strains
US5378824A (en) 1986-08-26 1995-01-03 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
WO1995004826A1 (en) 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
WO1995009910A1 (en) 1993-10-01 1995-04-13 Mitsubishi Corporation Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same
US5434283A (en) 1990-04-04 1995-07-18 Pioneer Hi-Bred International, Inc. Edible endogenous vegetable oil extracted from rapeseeds of reduced stearic and palmitic saturated fatty acid content
EP0663956A1 (en) 1992-08-12 1995-07-26 Hoechst Schering AgrEvo GmbH Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants
WO1995026407A1 (en) 1994-03-25 1995-10-05 National Starch And Chemical Investment Holding Corporation Method for producing altered starch from potato plants
US5463175A (en) 1990-06-25 1995-10-31 Monsanto Company Glyphosate tolerant plants
WO1995031553A1 (en) 1994-05-18 1995-11-23 Institut Für Genbiologische Forschung Berlin Gmbh DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR α-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS
WO1995035026A1 (en) 1994-06-21 1995-12-28 Zeneca Limited Novel plants and processes for obtaining them
WO1996001904A1 (en) 1994-07-08 1996-01-25 Stichting Scheikundig Onderzoek In Nederland Production of oligosaccharides in transgenic plants
WO1996015248A1 (en) 1994-11-10 1996-05-23 Hoechst Schering Agrevo Gmbh Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
WO1996019581A1 (en) 1994-12-22 1996-06-27 Hoechst Schering Agrevo Gmbh Dna molecules coding for debranching enzymes derived from plants
EP0719338A1 (en) 1993-09-09 1996-07-03 Hoechst Schering AgrEvo GmbH Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants and the modified starch obtainable therefrom
WO1996021023A1 (en) 1995-01-06 1996-07-11 Centrum Voor Plantenveredelings- En Reproduktieonderzoek (Cpro - Dlo) Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants
EP0728213A1 (en) 1993-11-09 1996-08-28 E.I. Du Pont De Nemours And Company Transgenic fructan accumulating crops and methods for their production
WO1996027674A1 (en) 1995-03-08 1996-09-12 Hoechst Schering Agrevo Gmbh Modified starch from plants, plants synthesizing this starch, and process for its preparation
US5561236A (en) 1986-03-11 1996-10-01 Plant Genetic Systems Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
WO1996033270A1 (en) 1995-04-20 1996-10-24 American Cyanamid Company Structure-based designed herbicide resistant products
WO1996034968A2 (en) 1995-05-05 1996-11-07 National Starch And Chemical Investment Holding Corporation Improvements in or relating to plant starch composition
WO1996038567A2 (en) 1995-06-02 1996-12-05 Rhone-Poulenc Agrochimie Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides
US5605011A (en) 1986-08-26 1997-02-25 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
WO1997011188A1 (en) 1995-09-19 1997-03-27 Planttec Biotechnologie Gmbh Plants which synthesise a modified starch, process for the production thereof and modified starch
US5637489A (en) 1986-08-23 1997-06-10 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
WO1997020936A1 (en) 1995-12-06 1997-06-12 Zeneca Limited Modification of starch synthesis in plants
WO1997026362A1 (en) 1996-01-16 1997-07-24 Planttec Biotechnologie Gmbh Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
WO1997032985A1 (en) 1996-03-07 1997-09-12 Planttec Biotechnologie Gmbh Forschung & Entwicklung Nucleic acid molecules coding for debranching enzymes from maize
WO1997041218A1 (en) 1996-04-29 1997-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Herbicide resistant rice
WO1997042328A1 (en) 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules which code the potato debranching enzyme
WO1997044472A1 (en) 1996-05-17 1997-11-27 Planttec Biotechnologie Gmbh Nucleic acid molecules coding soluble maize starch synthases
WO1997045545A1 (en) 1996-05-29 1997-12-04 Hoechst Schering Agrevo Gmbh Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
WO1997047807A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1997047808A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1997047806A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1998000549A1 (en) 1996-06-27 1998-01-08 The Australian National University MANIPULATION OF CELLULOSE AND/OR β-1,4-GLUCAN
US5712107A (en) 1995-06-07 1998-01-27 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
US5731180A (en) 1991-07-31 1998-03-24 American Cyanamid Company Imidazolinone resistant AHAS mutants
US5739082A (en) 1990-02-02 1998-04-14 Hoechst Schering Agrevo Gmbh Method of improving the yield of herbicide-resistant crop plants
EP0837944A2 (en) 1995-07-19 1998-04-29 Rhone-Poulenc Agrochimie Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene
WO1998020145A2 (en) 1996-11-05 1998-05-14 National Starch And Chemical Investment Holding Corporation Improvements in or relating to starch content of plants
WO1998022604A1 (en) 1996-11-20 1998-05-28 Pioneer Hi-Bred International, Inc. Methods of producing high-oil seed by modification of starch levels
WO1998027212A1 (en) 1996-12-19 1998-06-25 Planttec Biotechnologie Gmbh Novel nucleic acid molecules from maize and their use for the production of modified starch
US5773702A (en) 1996-07-17 1998-06-30 Board Of Trustees Operating Michigan State University Imidazolinone herbicide resistant sugar beet plants
WO1998027806A1 (en) 1996-12-24 1998-07-02 Pioneer Hi-Bred International, Inc. Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility
WO1998032326A2 (en) 1997-01-24 1998-07-30 Pioneer Hi-Bred International, Inc. Methods for $i(agrobacterium)-mediated transformation
WO1998039460A1 (en) 1997-03-04 1998-09-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nucleic acid molecules from artichoke ($i(cynara scolymus)) encoding enzymes having fructosyl polymerase activity
WO1998040503A1 (en) 1997-03-10 1998-09-17 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding starch phosphorylase from maize
US5824790A (en) 1994-06-21 1998-10-20 Zeneca Limited Modification of starch synthesis in plants
US5840946A (en) 1987-12-31 1998-11-24 Pioneer Hi-Bred International, Inc. Vegetable oil extracted from rapeseeds having a genetically controlled unusually high oleic acid content
WO1999012950A2 (en) 1997-09-06 1999-03-18 National Starch And Chemical Investment Holding Corporation Improvements in or relating to stability of plant starches
WO1999024585A1 (en) 1997-11-07 1999-05-20 Aventis Cropscience S.A. Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene
WO1999024593A1 (en) 1997-11-06 1999-05-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin
US5908810A (en) 1990-02-02 1999-06-01 Hoechst Schering Agrevo Gmbh Method of improving the growth of crop plants which are resistant to glutamine synthetase inhibitors
WO1999034008A1 (en) 1997-12-24 1999-07-08 Aventis Cropscience S.A. Method for enzymatic preparation of homogentisate
US5928937A (en) 1995-04-20 1999-07-27 American Cyanamid Company Structure-based designed herbicide resistant products
US5965755A (en) 1993-10-12 1999-10-12 Agrigenetics, Inc. Oil produced from the Brassica napus
US5969169A (en) 1993-04-27 1999-10-19 Cargill, Incorporated Non-hydrogenated canola oil for food applications
WO1999053072A1 (en) 1998-04-09 1999-10-21 E.I. Du Pont De Nemours And Company Starch r1 phosphorylation protein homologs
WO1999058690A2 (en) 1998-05-08 1999-11-18 Aventis Cropscience Gmbh Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
WO1999058688A2 (en) 1998-05-08 1999-11-18 Aventis Cropscience Gmbh Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
WO1999057965A1 (en) 1998-05-14 1999-11-18 Aventis Cropscience Gmbh Sulfonylurea-tolerant sugar beet mutants
WO1999058654A2 (en) 1998-05-13 1999-11-18 Planttec Biotechnologie Gmbh Forschung & Entwicklung Transgenic plants with a modified activity of a plastidial adp/atp translocator
WO1999066050A1 (en) 1998-06-15 1999-12-23 National Starch And Chemical Investment Holding Corporation Improvements in or relating to plants and plant products
US6013861A (en) 1989-05-26 2000-01-11 Zeneca Limited Plants and processes for obtaining them
WO2000004173A1 (en) 1998-07-17 2000-01-27 Aventis Cropscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
WO2000008185A1 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
WO2000008175A2 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
WO2000008184A1 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO2000011192A2 (en) 1998-08-25 2000-03-02 Pioneer Hi-Bred International, Inc. Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids
WO2000014249A1 (en) 1998-09-02 2000-03-16 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding an amylosucrase
WO2000022140A1 (en) 1998-10-09 2000-04-20 Planttec Biotechnologie Gmbh Forschung & Entwicklung NUCLEIC ACID MOLECULES WHICH CODE A BRANCHING ENZYME FROM BACTERIA OF THE GENUS NEISSERIA, AND A METHOD FOR PRODUCING α-1,6-BRANCHED α-1,4-GLUCANS
US6063947A (en) 1996-07-03 2000-05-16 Cargill, Incorporated Canola oil having increased oleic acid and decreased linolenic acid content
WO2000028052A2 (en) 1998-11-09 2000-05-18 Planttec Biotechnologie Gmbh Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch
WO2000047727A2 (en) 1999-02-08 2000-08-17 Planttec Biotechnologie Gmbh Forschung & Entwicklung Nucleic acid molecules encoding alternansucrase
WO2000066747A1 (en) 1999-04-29 2000-11-09 Syngenta Limited Herbicide resistant plants
WO2000066746A1 (en) 1999-04-29 2000-11-09 Syngenta Limited Herbicide resistant plants
WO2000073422A1 (en) 1999-05-27 2000-12-07 Planttec Biotechnologie Gmbh Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme
WO2000077229A2 (en) 1999-06-11 2000-12-21 Aventis Cropscience Gmbh R1 protein from wheat and the use thereof for the production of modified strach
WO2001012826A2 (en) 1999-08-11 2001-02-22 Aventis Cropscience Gmbh Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch
WO2001012782A2 (en) 1999-08-12 2001-02-22 Aventis Cropscience Gmbh Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
WO2001014569A2 (en) 1999-08-20 2001-03-01 Basf Plant Science Gmbh Increasing the polysaccharide content in plants
WO2001017333A1 (en) 1999-09-10 2001-03-15 Texas Tech University Transgenic fiber producing plants with increased expression of sucrose phosphate synthase
WO2001019975A2 (en) 1999-09-15 2001-03-22 National Starch And Chemical Investment Holding Corporation Plants having reduced activity in two or more starch-modifying enzymes
WO2001024615A1 (en) 1999-10-07 2001-04-12 Valigen (Us), Inc. Non-transgenic herbicide resistant plants
US6229072B1 (en) 1995-07-07 2001-05-08 Adventa Technology Ltd Cytoplasmic male sterility system production canola hybrids
US6270828B1 (en) 1993-11-12 2001-08-07 Cargrill Incorporated Canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability
US6284479B1 (en) 1995-06-07 2001-09-04 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
WO2001065922A2 (en) 2000-03-09 2001-09-13 E. I. Du Pont De Nemours And Company Sulfonylurea-tolerant sunflower plants
WO2001066704A2 (en) 2000-03-09 2001-09-13 Monsanto Technology Llc Methods for making plants tolerant to glyphosate and compositions thereof
US6323392B1 (en) 1999-03-01 2001-11-27 Pioneer Hi-Bred International, Inc. Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds
WO2001098509A2 (en) 2000-06-21 2001-12-27 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
WO2002012172A1 (en) 2000-08-08 2002-02-14 Dow Agrosciences Llc Unsaturated oxime ethers and their use as fungicides
WO2002026995A1 (en) 2000-09-29 2002-04-04 Syngenta Limited Herbicide resistant plants
WO2002034923A2 (en) 2000-10-23 2002-05-02 Bayer Cropscience Gmbh Monocotyledon plant cells and plants which synthesise modified starch
WO2002036782A2 (en) 2000-10-30 2002-05-10 Maxygen, Inc. Novel glyphosate n-acetyltransferase (gat) genes
WO2002036787A2 (en) 2000-10-30 2002-05-10 Bayer Cropscience S.A. Herbicide-tolerant plants through bypassing metabolic pathway
WO2002045485A1 (en) 2000-12-08 2002-06-13 Commonwealth Scienctific And Industrial Research Organisation Modification of sucrose synthase gene expression in plant tissue and uses therefor
WO2002079410A2 (en) 2001-03-30 2002-10-10 Basf Plant Science Gmbh Glucan chain length domains
WO2002101059A2 (en) 2001-06-12 2002-12-19 Bayer Cropscience Gmbh Transgenic plants synthesising high amylose starch
WO2003013226A2 (en) 2001-08-09 2003-02-20 Cibus Genetics Non-transgenic herbicide resistant plants
WO2003033540A2 (en) 2001-10-17 2003-04-24 Basf Plant Science Gmbh Starch
WO2003071860A2 (en) 2002-02-26 2003-09-04 Bayer Cropscience Gmbh Method for generating maize plants with an increased leaf starch content, and their use for making maize silage
WO2003092360A2 (en) 2002-04-30 2003-11-13 Verdia, Inc. Novel glyphosate-n-acetyltransferase (gat) genes
WO2004024928A2 (en) 2002-09-11 2004-03-25 Bayer Cropscience S.A. Transformed plants with enhanced prenylquinone biosynthesis
US6734341B2 (en) 1999-09-02 2004-05-11 Pioneer Hi-Bred International, Inc. Starch synthase polynucleotides and their use in the production of new starches
WO2004040012A2 (en) 2002-10-29 2004-05-13 Basf Plant Science Gmbh Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides
WO2004053219A2 (en) 2002-12-05 2004-06-24 Jentex Corporation Abrasive webs and methods of making the same
WO2004056999A1 (en) 2002-12-19 2004-07-08 Bayer Cropscience Gmbh Plant cells and plants which synthesize a starch with an increased final viscosity
WO2004058723A1 (en) 2002-12-24 2004-07-15 Syngenta Participations Ag Biphenyl derivatives and their use as fungicides
WO2004078983A2 (en) 2003-03-07 2004-09-16 Basf Plant Science Gmbh Enhanced amylose production in plants
WO2004090140A2 (en) 2003-04-09 2004-10-21 Bayer Bioscience N.V. Methods and means for increasing the tolerance of plants to stress conditions
WO2004106529A2 (en) 2003-05-28 2004-12-09 Basf Aktiengesellschaft Wheat plants having increased tolerance to imidazolinone herbicides
WO2005002324A2 (en) 2003-07-04 2005-01-13 Institut National De La Recherche Agronomique Method of producing double low restorer lines of brassica napus having a good agronomic value
WO2005002359A2 (en) 2003-05-22 2005-01-13 Syngenta Participations Ag Modified starch, uses, methods for production thereof
WO2005012515A2 (en) 2003-04-29 2005-02-10 Pioneer Hi-Bred International, Inc. Novel glyphosate-n-acetyltransferase (gat) genes
WO2005012529A1 (en) 2003-07-31 2005-02-10 Toyo Boseki Kabushiki Kaisha Plant producing hyaluronic acid
JP2005041793A (en) 2003-07-24 2005-02-17 Sumitomo Chemical Co Ltd Naphthalene compound and use thereof
WO2005017157A1 (en) 2003-08-15 2005-02-24 Commonwealth Scientific And Industrial Research Organisation (Csiro) Methods and means for altering fiber characteristics in fiber-producing plants
WO2005020673A1 (en) 2003-08-29 2005-03-10 Instituto Nacional De Technologia Agropecuaria Rice plants having increased tolerance to imidazolinone herbicides
WO2005030941A1 (en) 2003-09-30 2005-04-07 Bayer Cropscience Gmbh Plants with increased activity of a class 3 branching enzyme
WO2005030942A1 (en) 2003-09-30 2005-04-07 Bayer Cropscience Gmbh Plants with reduced activity of a class 3 branching enzyme
EP1559320A1 (en) 2002-10-31 2005-08-03 Ishihara Sangyo Kaisha, Ltd. 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
WO2005093093A2 (en) 2004-03-22 2005-10-06 Basf Aktiengesellschaft Methods and compositions for analyzing ahasl genes
WO2005095617A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with increased activity of a starch phosphorylating enzyme
WO2005095632A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Methods for identifying proteins with starch phosphorylating enzymatic activity
WO2005095618A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
WO2005095619A1 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with increased activity of multiple starch phosphorylating enzymes
WO2005123927A1 (en) 2004-06-21 2005-12-29 Bayer Cropscience Gmbh Plants that produce amylopectin starch with novel properties
WO2006007373A2 (en) 2004-06-16 2006-01-19 Basf Plant Science Gmbh Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants
WO2006015376A2 (en) 2004-08-04 2006-02-09 Basf Plant Science Gmbh Monocot ahass sequences and methods of use
WO2006018319A1 (en) 2004-08-18 2006-02-23 Bayer Cropscience Gmbh Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
WO2006021972A1 (en) 2004-08-26 2006-03-02 Dhara Vegetable Oil And Foods Company Limited A novel cytoplasmic male sterility system for brassica species and its use for hybrid seed production in indian oilseed mustard brassica juncea
WO2006024351A1 (en) 2004-07-30 2006-03-09 Basf Agrochemical Products B.V. Herbicide-resistant sunflower plants, plynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins, and methods of use
WO2006032538A1 (en) 2004-09-23 2006-03-30 Bayer Cropscience Gmbh Methods and means for producing hyaluronan
WO2006032469A2 (en) 2004-09-24 2006-03-30 Bayer Bioscience N.V. Stress resistant plants
WO2006045633A1 (en) 2004-10-29 2006-05-04 Bayer Bioscience N.V. Stress tolerant cotton plants
WO2006060634A2 (en) 2004-12-01 2006-06-08 Basf Agrochemical Products, B.V. Novel mutation involved in increased tolerance to imidazolinone herbicides in plants
WO2006063862A1 (en) 2004-12-17 2006-06-22 Bayer Cropscience Ag Transformed plant expressing a dextransucrase and synthesizing a modified starch
WO2006072603A2 (en) 2005-01-10 2006-07-13 Bayer Cropscience Ag Transformed plant expressing a mutansucrase and synthesizing a modified starch
WO2006103107A1 (en) 2005-04-01 2006-10-05 Bayer Cropscience Ag Phosphorylated waxy potato starch
WO2006108702A1 (en) 2005-04-08 2006-10-19 Bayer Cropscience Ag High-phosphate starch
JP2006304779A (en) 2005-03-30 2006-11-09 Toyobo Co Ltd Plant producing hexosamine in high productivity
WO2006133827A2 (en) 2005-06-15 2006-12-21 Bayer Bioscience N.V. Methods for increasing the resistance of plants to hypoxic conditions
WO2006136351A2 (en) 2005-06-24 2006-12-28 Bayer Bioscience N.V. Methods for altering the reactivity of plant cell walls
WO2007009823A1 (en) 2005-07-22 2007-01-25 Bayer Cropscience Ag Overexpression of starch synthase in plants
WO2007014290A2 (en) 2005-07-26 2007-02-01 E. I. Du Pont De Nemours And Company Fungicidal carboxamides
WO2007024782A2 (en) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions providing tolerance to multiple herbicides and methods of use thereof
WO2007027777A2 (en) 2005-08-31 2007-03-08 Monsanto Technology Llc Nucleotide sequences encoding insecticidal proteins
WO2007039316A1 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Improved methods and means for producings hyaluronan
WO2007039314A2 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Plants with increased hyaluronan production
WO2007039315A1 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Plants with an increased production of hyaluronan ii
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
WO2008148570A1 (en) 2007-06-08 2008-12-11 Syngenta Participations Ag Pyrazole carboxylic acid amides useful as microbiocides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26487A1 (en) * 1997-04-29 2004-12-20 Smithkline Beecham Corp PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US20050176791A1 (en) * 2002-02-13 2005-08-11 Oxford Alexander W. 5-HT2B receptor antagonists
JP2004155772A (en) * 2002-10-17 2004-06-03 Sumitomo Chem Co Ltd Naphthalene compound and use of the same as plant blight control
US20090018150A1 (en) * 2003-07-24 2009-01-15 Asterand Uk Limited 5-Ht2b Receptor Antagonists

Patent Citations (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
US5304732A (en) 1984-03-06 1994-04-19 Mgi Pharma, Inc. Herbicide resistance in plants
US5331107A (en) 1984-03-06 1994-07-19 Mgi Pharma, Inc. Herbicide resistance in plants
US5648477A (en) 1986-03-11 1997-07-15 Plant Genetic Systems, N.V. Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
US5561236A (en) 1986-03-11 1996-10-01 Plant Genetic Systems Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
US5646024A (en) 1986-03-11 1997-07-08 Plant Genetic Systems, N.V. Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
US7112665B1 (en) 1986-03-11 2006-09-26 Bayer Bioscience N.V. Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
US5637489A (en) 1986-08-23 1997-06-10 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5273894A (en) 1986-08-23 1993-12-28 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5276268A (en) 1986-08-23 1994-01-04 Hoechst Aktiengesellschaft Phosphinothricin-resistance gene, and its use
US5378824A (en) 1986-08-26 1995-01-03 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5605011A (en) 1986-08-26 1997-02-25 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5141870A (en) 1987-07-27 1992-08-25 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5013659A (en) 1987-07-27 1991-05-07 E. I. Du Pont De Nemours And Company Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase
US5840946A (en) 1987-12-31 1998-11-24 Pioneer Hi-Bred International, Inc. Vegetable oil extracted from rapeseeds having a genetically controlled unusually high oleic acid content
WO1989010396A1 (en) 1988-04-28 1989-11-02 Plant Genetic Systems N.V. Plants with modified stamen cells
US5084082A (en) 1988-09-22 1992-01-28 E. I. Du Pont De Nemours And Company Soybean plants with dominant selectable trait for herbicide resistance
US6013861A (en) 1989-05-26 2000-01-11 Zeneca Limited Plants and processes for obtaining them
WO1991002069A1 (en) 1989-08-10 1991-02-21 Plant Genetic Systems N.V. Plants with modified flowers
US5908810A (en) 1990-02-02 1999-06-01 Hoechst Schering Agrevo Gmbh Method of improving the growth of crop plants which are resistant to glutamine synthetase inhibitors
US5739082A (en) 1990-02-02 1998-04-14 Hoechst Schering Agrevo Gmbh Method of improving the yield of herbicide-resistant crop plants
US5434283A (en) 1990-04-04 1995-07-18 Pioneer Hi-Bred International, Inc. Edible endogenous vegetable oil extracted from rapeseeds of reduced stearic and palmitic saturated fatty acid content
US5198599A (en) 1990-06-05 1993-03-30 Idaho Resarch Foundation, Inc. Sulfonylurea herbicide resistance in plants
US5463175A (en) 1990-06-25 1995-10-31 Monsanto Company Glyphosate tolerant plants
US5776760A (en) 1990-06-25 1998-07-07 Monsanto Company Glyphosate tolerant plants
WO1992005251A1 (en) 1990-09-21 1992-04-02 Institut National De La Recherche Agronomique Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
EP0571427A1 (en) 1991-02-13 1993-12-01 Hoechst Schering AgrEvo GmbH Plasmids containing dna-sequences that cause changes in the carbohydrate concentration and the carbohydrate composition in plants, as well as plant cells and plants containing these plasmids
US5767361A (en) 1991-07-31 1998-06-16 American Cyanamid Company Imidazolinone resistant AHAS mutants
US5731180A (en) 1991-07-31 1998-03-24 American Cyanamid Company Imidazolinone resistant AHAS mutants
EP0663956A1 (en) 1992-08-12 1995-07-26 Hoechst Schering AgrEvo GmbH Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants
WO1994004693A2 (en) 1992-08-26 1994-03-03 Zeneca Limited Novel plants and processes for obtaining them
WO1994009144A1 (en) 1992-10-14 1994-04-28 Zeneca Limited Novel plants and processes for obtaining them
WO1994011520A2 (en) 1992-11-09 1994-05-26 Zeneca Limited Novel plants and processes for obtaining them
WO1994021795A1 (en) 1993-03-25 1994-09-29 Ciba-Geigy Ag Novel pesticidal proteins and strains
US5969169A (en) 1993-04-27 1999-10-19 Cargill, Incorporated Non-hydrogenated canola oil for food applications
WO1995004826A1 (en) 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
EP0719338A1 (en) 1993-09-09 1996-07-03 Hoechst Schering AgrEvo GmbH Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants and the modified starch obtainable therefrom
WO1995009910A1 (en) 1993-10-01 1995-04-13 Mitsubishi Corporation Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same
US6169190B1 (en) 1993-10-12 2001-01-02 Agrigenetics Inc Oil of Brassica napus
US5965755A (en) 1993-10-12 1999-10-12 Agrigenetics, Inc. Oil produced from the Brassica napus
EP0728213A1 (en) 1993-11-09 1996-08-28 E.I. Du Pont De Nemours And Company Transgenic fructan accumulating crops and methods for their production
US5908975A (en) 1993-11-09 1999-06-01 E. I. Du Pont De Nemours And Company Accumulation of fructans in plants by targeted expression of bacterial levansucrase
US6270828B1 (en) 1993-11-12 2001-08-07 Cargrill Incorporated Canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability
WO1995026407A1 (en) 1994-03-25 1995-10-05 National Starch And Chemical Investment Holding Corporation Method for producing altered starch from potato plants
WO1995031553A1 (en) 1994-05-18 1995-11-23 Institut Für Genbiologische Forschung Berlin Gmbh DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR α-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS
WO1995035026A1 (en) 1994-06-21 1995-12-28 Zeneca Limited Novel plants and processes for obtaining them
US5824790A (en) 1994-06-21 1998-10-20 Zeneca Limited Modification of starch synthesis in plants
WO1996001904A1 (en) 1994-07-08 1996-01-25 Stichting Scheikundig Onderzoek In Nederland Production of oligosaccharides in transgenic plants
WO1996015248A1 (en) 1994-11-10 1996-05-23 Hoechst Schering Agrevo Gmbh Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
WO1996019581A1 (en) 1994-12-22 1996-06-27 Hoechst Schering Agrevo Gmbh Dna molecules coding for debranching enzymes derived from plants
WO1996021023A1 (en) 1995-01-06 1996-07-11 Centrum Voor Plantenveredelings- En Reproduktieonderzoek (Cpro - Dlo) Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants
WO1996027674A1 (en) 1995-03-08 1996-09-12 Hoechst Schering Agrevo Gmbh Modified starch from plants, plants synthesizing this starch, and process for its preparation
US5928937A (en) 1995-04-20 1999-07-27 American Cyanamid Company Structure-based designed herbicide resistant products
WO1996033270A1 (en) 1995-04-20 1996-10-24 American Cyanamid Company Structure-based designed herbicide resistant products
WO1996034968A2 (en) 1995-05-05 1996-11-07 National Starch And Chemical Investment Holding Corporation Improvements in or relating to plant starch composition
WO1996038567A2 (en) 1995-06-02 1996-12-05 Rhone-Poulenc Agrochimie Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides
US5712107A (en) 1995-06-07 1998-01-27 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
US20020031826A1 (en) 1995-06-07 2002-03-14 Nichols Scott E. Glucan-containing compositions and paper
US6284479B1 (en) 1995-06-07 2001-09-04 Pioneer Hi-Bred International, Inc. Substitutes for modified starch and latexes in paper manufacture
US6229072B1 (en) 1995-07-07 2001-05-08 Adventa Technology Ltd Cytoplasmic male sterility system production canola hybrids
EP0837944A2 (en) 1995-07-19 1998-04-29 Rhone-Poulenc Agrochimie Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene
WO1997011188A1 (en) 1995-09-19 1997-03-27 Planttec Biotechnologie Gmbh Plants which synthesise a modified starch, process for the production thereof and modified starch
WO1997020936A1 (en) 1995-12-06 1997-06-12 Zeneca Limited Modification of starch synthesis in plants
WO1997026362A1 (en) 1996-01-16 1997-07-24 Planttec Biotechnologie Gmbh Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
WO1997032985A1 (en) 1996-03-07 1997-09-12 Planttec Biotechnologie Gmbh Forschung & Entwicklung Nucleic acid molecules coding for debranching enzymes from maize
WO1997041218A1 (en) 1996-04-29 1997-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Herbicide resistant rice
WO1997042328A1 (en) 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules which code the potato debranching enzyme
WO1997044472A1 (en) 1996-05-17 1997-11-27 Planttec Biotechnologie Gmbh Nucleic acid molecules coding soluble maize starch synthases
WO1997045545A1 (en) 1996-05-29 1997-12-04 Hoechst Schering Agrevo Gmbh Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
WO1997047807A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1997047808A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1997047806A1 (en) 1996-06-12 1997-12-18 Pioneer Hi-Bred International, Inc. Substitutes for modified starch in paper manufacture
WO1998000549A1 (en) 1996-06-27 1998-01-08 The Australian National University MANIPULATION OF CELLULOSE AND/OR β-1,4-GLUCAN
US6063947A (en) 1996-07-03 2000-05-16 Cargill, Incorporated Canola oil having increased oleic acid and decreased linolenic acid content
US5773702A (en) 1996-07-17 1998-06-30 Board Of Trustees Operating Michigan State University Imidazolinone herbicide resistant sugar beet plants
WO1998020145A2 (en) 1996-11-05 1998-05-14 National Starch And Chemical Investment Holding Corporation Improvements in or relating to starch content of plants
WO1998022604A1 (en) 1996-11-20 1998-05-28 Pioneer Hi-Bred International, Inc. Methods of producing high-oil seed by modification of starch levels
WO1998027212A1 (en) 1996-12-19 1998-06-25 Planttec Biotechnologie Gmbh Novel nucleic acid molecules from maize and their use for the production of modified starch
WO1998027806A1 (en) 1996-12-24 1998-07-02 Pioneer Hi-Bred International, Inc. Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility
WO1998032326A2 (en) 1997-01-24 1998-07-30 Pioneer Hi-Bred International, Inc. Methods for $i(agrobacterium)-mediated transformation
WO1998039460A1 (en) 1997-03-04 1998-09-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nucleic acid molecules from artichoke ($i(cynara scolymus)) encoding enzymes having fructosyl polymerase activity
WO1998040503A1 (en) 1997-03-10 1998-09-17 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding starch phosphorylase from maize
WO1999012950A2 (en) 1997-09-06 1999-03-18 National Starch And Chemical Investment Holding Corporation Improvements in or relating to stability of plant starches
WO1999024593A1 (en) 1997-11-06 1999-05-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin
WO1999024586A1 (en) 1997-11-07 1999-05-20 Aventis Cropscience S.A. Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance
WO1999024585A1 (en) 1997-11-07 1999-05-20 Aventis Cropscience S.A. Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene
WO1999034008A1 (en) 1997-12-24 1999-07-08 Aventis Cropscience S.A. Method for enzymatic preparation of homogentisate
WO1999053072A1 (en) 1998-04-09 1999-10-21 E.I. Du Pont De Nemours And Company Starch r1 phosphorylation protein homologs
WO1999058688A2 (en) 1998-05-08 1999-11-18 Aventis Cropscience Gmbh Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
WO1999058690A2 (en) 1998-05-08 1999-11-18 Aventis Cropscience Gmbh Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
WO1999058654A2 (en) 1998-05-13 1999-11-18 Planttec Biotechnologie Gmbh Forschung & Entwicklung Transgenic plants with a modified activity of a plastidial adp/atp translocator
WO1999057965A1 (en) 1998-05-14 1999-11-18 Aventis Cropscience Gmbh Sulfonylurea-tolerant sugar beet mutants
WO1999066050A1 (en) 1998-06-15 1999-12-23 National Starch And Chemical Investment Holding Corporation Improvements in or relating to plants and plant products
WO2000004173A1 (en) 1998-07-17 2000-01-27 Aventis Cropscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
WO2000008175A2 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
WO2000008185A1 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
WO2000008184A1 (en) 1998-07-31 2000-02-17 Aventis Cropscience Gmbh Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO2000011192A2 (en) 1998-08-25 2000-03-02 Pioneer Hi-Bred International, Inc. Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids
WO2000014249A1 (en) 1998-09-02 2000-03-16 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding an amylosucrase
WO2000022140A1 (en) 1998-10-09 2000-04-20 Planttec Biotechnologie Gmbh Forschung & Entwicklung NUCLEIC ACID MOLECULES WHICH CODE A BRANCHING ENZYME FROM BACTERIA OF THE GENUS NEISSERIA, AND A METHOD FOR PRODUCING α-1,6-BRANCHED α-1,4-GLUCANS
WO2000028052A2 (en) 1998-11-09 2000-05-18 Planttec Biotechnologie Gmbh Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch
WO2000047727A2 (en) 1999-02-08 2000-08-17 Planttec Biotechnologie Gmbh Forschung & Entwicklung Nucleic acid molecules encoding alternansucrase
US6323392B1 (en) 1999-03-01 2001-11-27 Pioneer Hi-Bred International, Inc. Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds
WO2000066747A1 (en) 1999-04-29 2000-11-09 Syngenta Limited Herbicide resistant plants
WO2000066746A1 (en) 1999-04-29 2000-11-09 Syngenta Limited Herbicide resistant plants
WO2000073422A1 (en) 1999-05-27 2000-12-07 Planttec Biotechnologie Gmbh Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme
WO2000077229A2 (en) 1999-06-11 2000-12-21 Aventis Cropscience Gmbh R1 protein from wheat and the use thereof for the production of modified strach
WO2001012826A2 (en) 1999-08-11 2001-02-22 Aventis Cropscience Gmbh Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch
WO2001012782A2 (en) 1999-08-12 2001-02-22 Aventis Cropscience Gmbh Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
WO2001014569A2 (en) 1999-08-20 2001-03-01 Basf Plant Science Gmbh Increasing the polysaccharide content in plants
US6734341B2 (en) 1999-09-02 2004-05-11 Pioneer Hi-Bred International, Inc. Starch synthase polynucleotides and their use in the production of new starches
WO2001017333A1 (en) 1999-09-10 2001-03-15 Texas Tech University Transgenic fiber producing plants with increased expression of sucrose phosphate synthase
WO2001019975A2 (en) 1999-09-15 2001-03-22 National Starch And Chemical Investment Holding Corporation Plants having reduced activity in two or more starch-modifying enzymes
WO2001024615A1 (en) 1999-10-07 2001-04-12 Valigen (Us), Inc. Non-transgenic herbicide resistant plants
WO2001066704A2 (en) 2000-03-09 2001-09-13 Monsanto Technology Llc Methods for making plants tolerant to glyphosate and compositions thereof
WO2001065922A2 (en) 2000-03-09 2001-09-13 E. I. Du Pont De Nemours And Company Sulfonylurea-tolerant sunflower plants
WO2001098509A2 (en) 2000-06-21 2001-12-27 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
WO2002012172A1 (en) 2000-08-08 2002-02-14 Dow Agrosciences Llc Unsaturated oxime ethers and their use as fungicides
WO2002026995A1 (en) 2000-09-29 2002-04-04 Syngenta Limited Herbicide resistant plants
WO2002034923A2 (en) 2000-10-23 2002-05-02 Bayer Cropscience Gmbh Monocotyledon plant cells and plants which synthesise modified starch
WO2002036782A2 (en) 2000-10-30 2002-05-10 Maxygen, Inc. Novel glyphosate n-acetyltransferase (gat) genes
WO2002036787A2 (en) 2000-10-30 2002-05-10 Bayer Cropscience S.A. Herbicide-tolerant plants through bypassing metabolic pathway
WO2002045485A1 (en) 2000-12-08 2002-06-13 Commonwealth Scienctific And Industrial Research Organisation Modification of sucrose synthase gene expression in plant tissue and uses therefor
WO2002079410A2 (en) 2001-03-30 2002-10-10 Basf Plant Science Gmbh Glucan chain length domains
WO2002101059A2 (en) 2001-06-12 2002-12-19 Bayer Cropscience Gmbh Transgenic plants synthesising high amylose starch
WO2003013226A2 (en) 2001-08-09 2003-02-20 Cibus Genetics Non-transgenic herbicide resistant plants
WO2003033540A2 (en) 2001-10-17 2003-04-24 Basf Plant Science Gmbh Starch
WO2003071860A2 (en) 2002-02-26 2003-09-04 Bayer Cropscience Gmbh Method for generating maize plants with an increased leaf starch content, and their use for making maize silage
WO2003092360A2 (en) 2002-04-30 2003-11-13 Verdia, Inc. Novel glyphosate-n-acetyltransferase (gat) genes
WO2004024928A2 (en) 2002-09-11 2004-03-25 Bayer Cropscience S.A. Transformed plants with enhanced prenylquinone biosynthesis
WO2004040012A2 (en) 2002-10-29 2004-05-13 Basf Plant Science Gmbh Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides
EP1559320A1 (en) 2002-10-31 2005-08-03 Ishihara Sangyo Kaisha, Ltd. 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
WO2004053219A2 (en) 2002-12-05 2004-06-24 Jentex Corporation Abrasive webs and methods of making the same
WO2004056999A1 (en) 2002-12-19 2004-07-08 Bayer Cropscience Gmbh Plant cells and plants which synthesize a starch with an increased final viscosity
WO2004058723A1 (en) 2002-12-24 2004-07-15 Syngenta Participations Ag Biphenyl derivatives and their use as fungicides
WO2004078983A2 (en) 2003-03-07 2004-09-16 Basf Plant Science Gmbh Enhanced amylose production in plants
WO2004090140A2 (en) 2003-04-09 2004-10-21 Bayer Bioscience N.V. Methods and means for increasing the tolerance of plants to stress conditions
WO2005012515A2 (en) 2003-04-29 2005-02-10 Pioneer Hi-Bred International, Inc. Novel glyphosate-n-acetyltransferase (gat) genes
WO2005002359A2 (en) 2003-05-22 2005-01-13 Syngenta Participations Ag Modified starch, uses, methods for production thereof
WO2004106529A2 (en) 2003-05-28 2004-12-09 Basf Aktiengesellschaft Wheat plants having increased tolerance to imidazolinone herbicides
WO2005002324A2 (en) 2003-07-04 2005-01-13 Institut National De La Recherche Agronomique Method of producing double low restorer lines of brassica napus having a good agronomic value
JP2005041793A (en) 2003-07-24 2005-02-17 Sumitomo Chemical Co Ltd Naphthalene compound and use thereof
WO2005012529A1 (en) 2003-07-31 2005-02-10 Toyo Boseki Kabushiki Kaisha Plant producing hyaluronic acid
WO2005017157A1 (en) 2003-08-15 2005-02-24 Commonwealth Scientific And Industrial Research Organisation (Csiro) Methods and means for altering fiber characteristics in fiber-producing plants
WO2005020673A1 (en) 2003-08-29 2005-03-10 Instituto Nacional De Technologia Agropecuaria Rice plants having increased tolerance to imidazolinone herbicides
WO2005030941A1 (en) 2003-09-30 2005-04-07 Bayer Cropscience Gmbh Plants with increased activity of a class 3 branching enzyme
WO2005030942A1 (en) 2003-09-30 2005-04-07 Bayer Cropscience Gmbh Plants with reduced activity of a class 3 branching enzyme
WO2005095632A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Methods for identifying proteins with starch phosphorylating enzymatic activity
WO2005095617A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with increased activity of a starch phosphorylating enzyme
WO2005095618A2 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
WO2005095619A1 (en) 2004-03-05 2005-10-13 Bayer Cropscience Gmbh Plants with increased activity of multiple starch phosphorylating enzymes
WO2005093093A2 (en) 2004-03-22 2005-10-06 Basf Aktiengesellschaft Methods and compositions for analyzing ahasl genes
WO2006007373A2 (en) 2004-06-16 2006-01-19 Basf Plant Science Gmbh Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants
WO2005123927A1 (en) 2004-06-21 2005-12-29 Bayer Cropscience Gmbh Plants that produce amylopectin starch with novel properties
WO2006024351A1 (en) 2004-07-30 2006-03-09 Basf Agrochemical Products B.V. Herbicide-resistant sunflower plants, plynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins, and methods of use
WO2006015376A2 (en) 2004-08-04 2006-02-09 Basf Plant Science Gmbh Monocot ahass sequences and methods of use
WO2006018319A1 (en) 2004-08-18 2006-02-23 Bayer Cropscience Gmbh Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
WO2006021972A1 (en) 2004-08-26 2006-03-02 Dhara Vegetable Oil And Foods Company Limited A novel cytoplasmic male sterility system for brassica species and its use for hybrid seed production in indian oilseed mustard brassica juncea
WO2006032538A1 (en) 2004-09-23 2006-03-30 Bayer Cropscience Gmbh Methods and means for producing hyaluronan
WO2006032469A2 (en) 2004-09-24 2006-03-30 Bayer Bioscience N.V. Stress resistant plants
WO2006045633A1 (en) 2004-10-29 2006-05-04 Bayer Bioscience N.V. Stress tolerant cotton plants
WO2006060634A2 (en) 2004-12-01 2006-06-08 Basf Agrochemical Products, B.V. Novel mutation involved in increased tolerance to imidazolinone herbicides in plants
WO2006063862A1 (en) 2004-12-17 2006-06-22 Bayer Cropscience Ag Transformed plant expressing a dextransucrase and synthesizing a modified starch
WO2006072603A2 (en) 2005-01-10 2006-07-13 Bayer Cropscience Ag Transformed plant expressing a mutansucrase and synthesizing a modified starch
JP2006304779A (en) 2005-03-30 2006-11-09 Toyobo Co Ltd Plant producing hexosamine in high productivity
WO2006103107A1 (en) 2005-04-01 2006-10-05 Bayer Cropscience Ag Phosphorylated waxy potato starch
WO2006108702A1 (en) 2005-04-08 2006-10-19 Bayer Cropscience Ag High-phosphate starch
WO2006133827A2 (en) 2005-06-15 2006-12-21 Bayer Bioscience N.V. Methods for increasing the resistance of plants to hypoxic conditions
WO2006136351A2 (en) 2005-06-24 2006-12-28 Bayer Bioscience N.V. Methods for altering the reactivity of plant cell walls
WO2007009823A1 (en) 2005-07-22 2007-01-25 Bayer Cropscience Ag Overexpression of starch synthase in plants
WO2007014290A2 (en) 2005-07-26 2007-02-01 E. I. Du Pont De Nemours And Company Fungicidal carboxamides
WO2007024782A2 (en) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions providing tolerance to multiple herbicides and methods of use thereof
WO2007027777A2 (en) 2005-08-31 2007-03-08 Monsanto Technology Llc Nucleotide sequences encoding insecticidal proteins
WO2007039316A1 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Improved methods and means for producings hyaluronan
WO2007039314A2 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Plants with increased hyaluronan production
WO2007039315A1 (en) 2005-10-05 2007-04-12 Bayer Cropscience Ag Plants with an increased production of hyaluronan ii
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
WO2008148570A1 (en) 2007-06-08 2008-12-11 Syngenta Participations Ag Pyrazole carboxylic acid amides useful as microbiocides

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BARRY ET AL., CURR. TOPICS PLANT PHYSIOL., vol. 7, 1992, pages 139 - 145
COMAI ET AL., SCIENCE, vol. 221, 1983, pages 370 - 371
CRICKMORE ET AL., MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, vol. 62, 1998, pages 807 - 813
GASSER ET AL., J. BIOL. CHEM., vol. 263, 1988, pages 4280 - 4289
MOELLENBECK ET AL., NAT. BIOTECHNOL., vol. 19, 2001, pages 668 - 72
SCHNEPF ET AL., APPLIED ENVIRONM. MICROBIOL., vol. 71, 2006, pages 1765 - 1774
SHAH ET AL., SCIENCE, vol. 233, 1986, pages 478 - 481
TRANEL; WRIGHT, WEED SCIENCE, vol. 50, 2002, pages 700 - 712

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071495A (en) * 2016-04-13 2018-12-21 瑞戴格作物保护公司 Agricultural chemicals
JP2019513785A (en) * 2016-04-13 2019-05-30 レダッグ クロップ プロテクション リミテッド Pesticide
CN109071495B (en) * 2016-04-13 2022-04-19 瑞戴格作物保护公司 Agricultural chemicals
US11641858B2 (en) 2016-04-13 2023-05-09 Redag Crop Protection Ltd. Agricultural chemicals
JP2020505347A (en) * 2017-01-13 2020-02-20 レダッグ クロップ プロテクション リミテッド Thiobenzimidazole as a fungicide
US11014908B2 (en) 2018-11-29 2021-05-25 Pfizer Inc. Chemical compounds
US11702405B2 (en) 2018-11-29 2023-07-18 Pfizer Inc. Chemical compounds

Also Published As

Publication number Publication date
WO2011015524A3 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
US9695126B2 (en) Fungicide pyrazole carboxamides derivatives
US9000012B2 (en) Fungicide hydroximoyl-heterocycles derivatives
JP2013541553A (en) 1- (Heterocycliccarbonyl) piperidines
US20130045995A1 (en) Fungicide hydroximoyl-heterocycles derivatives
US8372982B2 (en) Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
JP2014502611A (en) Fungicide hydroxymoyl-tetrazole derivative
JP5847169B2 (en) Bactericidal N-[(trisubstituted silyl) methyl] -carboxamide derivatives
WO2011015524A2 (en) Fungicide heterocycles derivatives
WO2011134911A2 (en) Fungicide hydroximoyl-tetrazole derivatives
US20130116287A1 (en) Fungicide hydroximoyl-heterocycles derivatives
WO2012123434A1 (en) Fungicide hydroximoyl-tetrazole derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10739355

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10739355

Country of ref document: EP

Kind code of ref document: A2